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Catheter-associated infections (CAIs) as one of the most common 
medical devices-associated infections (MDAIs) have caused significant 
morbidity, mortality and costs. Bacterial biofilm formation on catheter 
surfaces is the major cause for the CAIs, and also leads to failure of 
conventional antibiotics treatment. To prevent the bacterial biofilm formation, 
antibacterial and antifouling coatings as two of the most promising strategies 
to kill bacteria and prevent bacterial adhesion have been applied. However, the 
need for a facile, nontoxic and effective anti-infective coating on catheter 
surfaces is still pressing. The objective of this study was to design 
biocompatible polymer coatings with antibacterial and antifouling activities, 
and to fabricate them in a facile manner. It is postulated that the 
aforementioned coatings can be achieved by incorporating mussel-inspired 
dopamine/polydopamine (PDA), cations and poly (ethylene glycol) (PEG) as 
adhesive, antibacterial and antifouling moieties in coating systems. To assess 
this hypothesis, this study was aimed to: 
(1): Design diblock copolymers of PEG-b-cationic polycarbonates and 
coat these copolymers onto silicone rubber surfaces by a two-step process: (1) 
attaching a reactive PDA layer onto catheter surface and (2) grafting the 
copolymers onto the PDA layer via the Michael addition reaction between the 
thiol group in the copolymers and oxidized catechol group in PDA. It was 
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demonstrated that these polymer coatings exhibited excellent antibacterial 
activity against notorious bacteria S. aureus including methicillin-resistant S. 
aureus (MRSA), and efficiently prevented their fouling on surfaces. 
Furthermore, these coatings inhibited biofilm formation without causing 
significant hemolysis, blood protein adsorption or platelet adhesion.  
(2): Broaden antibacterial spectrum and enhance antifouling activities of 
the aforementioned copolymer coatings by designing a PEG-based 
antimicrobial hydrogel coating on silicone surfaces. Thiol-containing 
tetra-sulfhydryl PEG was first coated on PDA treated silicone surfaces, 
followed by in situ hydrogel formation via Michael addition by adding 
tetra-acrylate PEG conjugated with PEG-b-cationic polycarbonates. This 
hydrogel displayed excellent antibacterial activity against both Gram-positive 
bacteria S. aureus and Gram-negative bacteria E. coli through a contact-based 
killing mechanism. In addition, the antifouling activity of this hydrogel to 
prevent bacterial adhesion was superior to hydrogel with only the PEG 
network.  
(3): Further simplify the coating process by chemically incorporating 
dopamine into the copolymers of PEG and cations. These brush-like 
copolymers that contain an optimized number of dopamine were readily 
coated onto silicone surfaces via a one-step immersion. The coating 
mechanism of the polymers containing dopamine was explored through 
comparing polymers with different compositions. By adjusting hydrophobicity 
 ix 
 
of quaternization agent of the polymers, polymer coatings with 
broad-spectrum antibacterial activity against both Gram-positive and 
Gram-negative bacteria were obtained. Importantly, these polymer coatings 
were stable under simulated blood flow condition, and their antibacterial and 
antifouling activities remained even after being in contact with bacterial 
suspension for over two weeks. Moreover, these coatings were 
hemocompatible.  
In conclusion, the findings of this thesis supported the hypothesis that 
polymer coatings with the incorporation of dopamine/PDA, cations and PEG 
can be easily fabricated and possess excellent antibacterial and antifouling 
activities with good biocompatibility, providing a potential solution for 
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Chapter 1. Introduction 
In an aging society, various medical devices are increasingly used to 
improve patients’ quality of life and also to extend their life expectancy. 
However, medical device-associated infections (MDAIs) are responsible for a 
large portion of nosocomial infections, which have thus and undermined the 
purposes of applications of these medical devices.1, 2 In particular, 
catheter-associated infections (CAIs) are one of the most common and serious 
MDAIs. These infections are usually caused by the formation of bacterial 
biofilm on catheter surfaces.3, 4 To prevent biofilm formation and occurrences 
of CAIs, facile, non-toxic and effective coatings are urgently needed. In this 
chapter, an overview of catheter-associated infections and various strategies 
for prevention of CAIs will be discussed. 
1.1 Catheter-associated infections (CAIs) 
Catheters are tubular medical devices that are inserted into human body 
mainly to administer drugs and fluids for patients. More specifically, 
intravascular catheters are used to deliver fluids or drugs into bloodstream, and 
urinary catheters are used for drainage of waste fluids.5 In the modern medical 
care system, the insertion of these catheters has, at times, become inevitable. 
And yet, catheter insertion could result in serious bacterial infections.6, 7 In the 
USA alone, more than 5 million intravascular catheters are used each year and 
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CAIs have been reported in up to 8% of all inserted catheters, resulting in 
considerable morbidity and mortality.8, 9 Additional financial costs attributable 
to CAIs can reach USD30,000 for each episode of infection, along with 
prolonged hospitalization.9, 10 In Europe, it was reported that  more than 60% 
of nosocomial infections are related to the usage of intravascular catheters.5 
The CAIs are caused mainly by the adhesion of microbes and the 
subsequent formation of a microbial biofilm which is a community of 
microbes and the extracellular polymeric substances secreted by the microbes 
on the device surfaces.3, 11 The biofilm then acts like a microbe reservoir to 
release microbes into the human bodies resulting in CAIs. In terms of 
intravascular-associated bloodstream infections, the bacteria most often 
isolated from the infected catheters are Gram positive S. epidermidis and 
followed by S. aureus.6 The most common bacteria found in infected urinary 
catheters are E. faecalis and E. coli.5  
The interactions between bacteria and device surfaces play a critical role 
during the development of CAIs.1, 11 In order to gain an understanding of CAIs 
and design an effective anti-infective coating system on catheter surfaces, 
bacterial biofilm development on surfaces and the effects of surface properties 
on bacteria attachment and biofilm formation will be reviewed in the next 
section.  
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1.2  Bacterial biofilm 
1.2.1 Bacteria-surface interaction and biofilm formation 
Over the past few decades, various materials have been fabricated for 
biomedical applications, especially medical devices. In particular, polymers 
(e.g. polyethylene, polyurethane, silicone rubber and PET) are widely applied 
in medical devices such as catheters and vascular grafts. However, due to the 
hydrophobic nature of these materials, device surfaces favour bacterial 
attachment and subsequent biofilm formation.6 In general, bacterial biofilm 
formation as shown in Figure 1.1 comprises of five main steps: initial 
attachment, irreversible attachment, initial growth, final growth of complex 
biofilm and detachment of bacteria.3, 4 When medical devices come in contact 
with bodily fluids, organic or inorganic nutrients such as proteins, they can 
quickly form a conditioning layer that facilitates bacterial attachment and 
provides nutrients for the attached bacteria. After surface conditioning, 
bacteria could attach themselves on surfaces of the catheter and form a 
complex biofilm. The bacteria could also detach from the biofilm and be 
released into bodily fluids, leading to bloodstream or urinary tract infections. 
These infections are extremely difficult to eradicate due to the presence of the 
bacterial biofilm. Once biofilm is formed on the surface, bacteria in the 
biofilm could have altered their phenotype, showing different growth rates and 
gene expression compared to that of planktonic bacteria. This alteration could 
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make some antibiotics that target specific genes ineffective. In addition, 
extracellular polymeric substances secreted by bacteria in the biofilm envelop 
the bacteria, and these substances act as a physical barrier to further protect 
bacteria from antibiotic attack and the innate immune response.4, 6 Biofilm has 
become a hallmark of MDAIs, as biofilm phenotypes could exhibit more than 
1,000 times greater minimum inhibitory concentrations (MIC) of clinical 
antibiotics in comparison to the non-biofilm strains.12-15 Due to the virulence 
of bacterial biofilm, biofilm-related infections such as blood stream infections 
and urinary tract infections are extremely difficult to treat. Therefore, it is 
quite important to prevent biofilm formation. To be more specific, the 
prevention of initial bacterial attachment is extremely desirable for medical 
device surfaces.    
 
Figure 1.1 The biofilm formation: initial attachment, irreversible attachment, 
initial growth, the growth of complex biofilms, and detachment of bacteria. 
(Reprinted with permission from Ref.3)  
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1.2.2 Strategies for prevention and eradication of bacterial biofilm 
To address the problem of CAIs, great efforts have been devoted to 
developing various strategies to eradicate formed biofilm or to prevent biofilm 
formation on device surfaces. To eradicate biofilm, one of the most common 
approaches used in hospitals is to remove infected catheters. This is necessary 
if the microorganisms isolated from devices are highly virulent and difficult to 
treat, but frequent removal of device could pose more risks to patients, in 
addition to increasing patients’ financial cost. Alternatively, salvaging of the 
device with antimicrobial agents like antibiotics is also a popular option. 
However, the presence of biofilm could makes antimicrobial treatment 
ineffective and overuse of antibiotics may induce drug-resistant bacterial 
strains.16 Thus, eradication of biofilm and curing the infection is relatively 
difficult, while prevention of the infection is easier and more practical. The 
most important and simplest strategy to prevent CAIs is hand and skin 
antisepsis as well as standardization of aseptic care,17-19 but it is difficult to 
meet the high requirement of aseptic care, especially for developing countries. 
In addition, usage of antibiotic-lock or ethanol-lock is recommended for 
catheters,18 but these techniques may result in the emergence of more 
superbugs or systematic toxicity.16, 20 Therefore, there is a pressing need to 
develop effective and facile approaches to prevent CAIs. Surface modification 
of medical devices has been frequently reported as a promising approach to 
prevent biofilm formation.11, 18 
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The bacterial attachment is critically influenced by surface properties of 
the device, such as surface morphology, hydrophobicity/hydrophilicity and 
surface chemistry. It was reported that bacterial attachment was successfully 
inhibited by using smooth surfaces rather than rough or porous surfaces.21 In 
addition, hydrophilic surfaces were reported to decrease bacterial attachment 
in contrast to hydrophobic surfaces.22 Cationic surfaces were also found to kill 
the bacteria in contact with the surfaces and prevent bacterial fouling on 
surfaces.23-25 Therefore, approaches by modulating surface properties with 
different coating materials and techniques to inhibit bacterial biofilm 
formation are very promising, and some of these strategies are summarized in 
Figure 1.2.26 Particularly, antifouling coatings and antibacterial coatings are 
prevalent in the field for the prevention of CAIs and other MDAIs. 
The purpose of this study is to modify device surfaces by coating them 
with antibacterial and antifouling polymers in a facile manner for the 
prevention of bacterial adhesion and subsequent CAIs. To better understand 
this concept, a detailed review on current antibacterial and antifouling coatings 
will be given in the following sections.  




Figure 1.2 Different strategies developed to prevent the MDAIs. (Reprinted 
with permission from Ref.26) 
1.3 Antibacterial coatings 
An antibacterial coating is defined as a coating of intrinsically bioactive 
material with surface antibacterial properties. The antibacterial coatings act by 
either releasing of antibacterial agents from surfaces or direct killing bacteria 
when the bacteria come in contact with the coatings. 
1.3.1 Coatings delivering antibacterial agents   
Delivering active antibacterial agents such as conventional antibiotics 
and silver in a controlled manner from surface coatings is one of the most 
direct approaches to prevent MDAIs. The advantage of delivering these 
antibacterial agents from surface coatings over intravenous injections is that a 
high local dose can be administered while the systematic toxicity level is not 
exceeded. The efficacy of the antibacterial agents-releasing coatings is 
strongly dependent on the coating matrix where the antibacterial agents are 
loaded.12  
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1.3.1.1 Coatings delivering antibiotics   
Various antibiotics including vancomycin, tobramycin, cefamandole, 
cephalothin, carbenicillin, amoxicillin, and gentamicin have been incorporated 
into hydroxyapatite coatings on implant surfaces.27-29 To prolong the release 
profiles of antibiotics and enhance tissue integration, self-assembly 
multilayers and hydrogels have recently been used to load antibiotics.30-32 
Although these antibiotic delivery systems exhibited excellent antibacterial 
activity, the overuse of antibiotics could induce multidrug-resistant bacteria 
and techniques like multilayer assembly are too complex to be used in clinic 
applications. While various antibiotics adsorbed or coated surfaces have been 
reported in recent years, a minocycline-rifampicin coated catheter (Cook 
Spectrum™ catheter) is currently the only marketed antibiotic-coated catheter 
which is able to effectively control infections. However, antibiotic-bound 
catheters are only recommended for high-risk patients with catheterization 
more than 5 days due to the potential development of multidrug-resistant 
bacteria.33  
1.3.1.2 Coatings delivering silver   
Apart from antibiotics, the most traditional antibacterial agents Ag/Ag+ 
have also been used to coat medical device surfaces for the prevention of 
MDAIs. The biocidal activity of silver is mainly attributed to the release of 
silver ions (Ag+), which can interact with important enzymes, proteins and 
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increase DNA mutation frequency.34-37 Ag+ also can displace metal ions like 
Zn2+ and Ca2+ which are essential for the survival of bacterial cells. Ag+ has 
demonstrated antibacterial efficacy against a broad spectrum of pathogens 
found at implant sites including P. aeruginosa, E. coli, S. aureus, and S. 
epidermidis. Typically, antibacterial silver (elemental silver, nanoparticulate 
silver, ionic silver and silver nanocomposite) is incorporated into a polymeric 
matrix or a thin film like polyethylene, poly (vinyl alcohol) and 
hydroxyapatite.38-41 Although Ag/Ag+ coatings are effective in killing bacteria, 
its toxicity to the human body remains a concern. Some reports claim that 
silver is biocompatible,38, 41 but a large number of reports have shown that 
silver can damage eukaryotic cells and tissues, and also induce undesirable 
cell responses.35, 37, 42, 43 For example, coatings with silver nanoparticles on 
catheter surfaces could accelerate blood coagulation when the coatings come 
in direct contact with blood immidiately.42, 43 The different sensitivity to silver 
ions of different cell lines may be the reason why different cytotoxic responses 
have been reported by various researchers. Nonetheless, silver-coated 
intravascular catheters should be used with more cautions due to their poor 
blood compatibility.   
In addition to coatings releasing antibiotics and silver, antibacterial 
xerogel coatings which function through the releasing of nitric oxide or 
reactive oxygen species have also been reported,44 45 but the effectiveness of 
these coatings can only last for a few days due to their limited loading amount.  
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1.3.2 Surfaces immobilized with antibacterial agents   
Given the drawbacks of the coatings that involve the controlled release of 
antibiotics, silver, nitric oxide and reactive oxygen (potential development of 
drug-resistant superbugs, mammalian cytotoxicity and limited life-time), 
alternative approaches by immobilizing antibacterial compounds on medical 
device surfaces have been proposed and demonstrated to be capable of 
preventing the biofilm formation without releasing a large amount of toxic 
substances into the human body. The advantages of covalently immobilizing 
antibacterial agents on the surfaces of medical devices are their long-lasting 
antibacterial activity and the non-accumulation of toxic antibacterial agents in 
tissues.  
1.3.2.1 Surfaces immobilized with antibiotics   
Antibiotics such as vancomycin,46 penicillin47 and ampicillin48 have been 
successfully attached onto titanium and expanded polytetrafluoroethylene 
(ePTFE) through a PEG-spacer, and these surfaces have displayed high 
antibacterial activity. However, the effectiveness of these coatings is strongly 
dependent on the spectrum of activity of the chosen antibiotics, and many 
antibiotics may no longer be active when chemically grafted onto medical 
device surfaces due to the requirement for intracellular action.15, 49  
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1.3.2.2 Surfaces immobilized with antimicrobial peptides (AMPs)   
As another approach, antimicrobial peptides (AMPs) can also be grafted 
onto medical device surfaces. AMPs are generally defined as a peptide with 
less than 50 amino acid residues carrying a net positive charge due to the 
presence of multiple lysine and arginine residues, and have a substantial 
portion of hydrophobic residues.50, 51 Compared to other antibacterial agents, 
AMPs have several attractive advantages: 1) broad-spectrum antibacterial 
activity at low concentrations; 2) less likely to induce bacterial resistance due 
to the membrane disruption mechanism.49, 52, 53 In general, these peptides act 
by disrupting the structural integrity of the microbial membranes. Cationic 
AMPs are firstly attracted to anionic bacterial membranes, and then form a 
secondary structure on the membrane surfaces, allowing for the insertion of 
hydrophobic components into the membrane lipid domains, disrupting the 
membrane structure.52 Covalent immobilization of AMPs onto surfaces 
increases their long-term stability and decreases their toxicity, as compared to 
the systems that release AMPs. Therefore, this strategy has attracted much 
interest recently amongst the scientific community. Various substrates with 
chemical immobilized AMPs have been assessed including glass slides,54 
silanized titanium,55 oxidized polyethylene film56 and commercial contact 
lenses.57. Most AMPs are randomly immobilized onto surfaces via the use of 
amide bond formation between amine group in AMPs and carboxyl groups on 
the treated surfaces or vice versa. However, it is more desirable to control the 
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orientation of the AMPs on the surfaces, since peptide structures have be 
shown to be related to antibacterial activity.49 One of the best ways to control 
the orientation of immobilized AMPs is to synthesize AMPs directly from the 
surfaces through the well-established solid-phase peptide synthesis method 
such as Fmoc/tBu strategy. Another alternative is to incorporate specific amino 
acids into AMPs at selected positions where AMPs are chemically bound to 
functionalized surfaces. For example, an additional cysteine which has a thiol 
functional group is commonly incorporated into the AMP chain with the 
purpose of immobilizing AMPs onto thiol-, maleimide- or epoxide-modified 
surfaces.49, 50, 58 Although a wide variety of AMPs have been grafted onto 
surfaces with different strategies and shown good antibacterial activity, the 
high cost of AMPs limited their applicatinos as coatings for inexpensive 
medical devices like catheters. In addition, it is necessary to functionalize the 
surfaces of substrates to facilitate chemical grafting of AMPs onto surfaces, 
and the surface functionalization is usually complicated. This extra process 
further prevents the usage of AMPs as antibacterial coatings for catheters.                      
1.3.2.3 Surfaces immobilized with cationic polymers 
Cationic polymers, another type of well-known antibacterial agents, have 
also been attached onto surfaces to generate an antibacterial coating. 
Polymeric quaternary ammonium compounds (QACs) are the most widely 
studied cationic polymers. Although polymeric phosphonium compounds were 
                                                                    
13 
 
reported to have similar antibacterial activity as compared to polymeric QACs, 
the polymeric QACs are more synthetically accessible. Therefore, the focus of 
this section will be on polymeric QACs and polymeric QACs-immobilized 
surfaces.  
It is generally accepted that similar to AMPs, quaternary ammonium 
compounds disturb bacterial membrane and cause membrane leakage, 
resulting in lysis of bacterial cells. Two predominant mechanisms have been 
proposed to support the membrane-disrupting theory. Bacterial membranes 
generally comprise of a peptidoglycan outer layer and a phospholipid inner 
membrane, and Gram-negative bacteria have an extra phospholipid layer. The 
first mechanism supposedly involves quaternary ammonium compounds 
penetrating through peptidoglycan and disordering phospholipid layer, leading 
to the leakage of bacterial cells.15, 59 This mechanism is based on the fact that 
only amphiphilic quaternary ammonium compounds which match with the 
phospholipids are able to kill bacteria. The second proposed mechanism 
supposes that quaternary ammonium compounds need to attach onto anionic 
bacterial outer membrane. Then, positive charged species enter into the 
bacterial membrane and replace another cation Ca2+ which is not only a 
counter ion, but also maintains the integrity of cell membrane.60 This 
exchanges of a calcium ion with a quaternary ammonium, in due concentration, 
could eventually lead to complete disintegration of the bacterial membrane 
corresponding to a bactericidal effect.15, 61 
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 Interestingly, mammalian cells respond to the quaternary ammonium 
compounds to a lesser extent, probably due to different cell membrane 
structure with bacteria. As shown in Figure 1.3, mammalian cells contain more 
zwitterionic phospholipids in the membrane outer leaflet, while bacterial cells 
possess more acidic phospholipids. This difference results in more negative 
charge and more counter ions Ca2+ in the bacterial membrane outer leaflet. As 
aforementioned, Ca2+ can be replaced by quaternary ammonium compounds 
leading to a disruption in the bacterial membrane. Therefore, the different 
cytotoxic responses are attributed to the different membrane phospholipid 
structures.62 However, further studies need to be carried out to confirm this 
hypothesis. 
 
Figure 1.3 The membrane target of cationic antimicrobial agents of 
multicellular organisms and the basis of specificity. (Reprinted with 
permission from Ref.62 )  




A large number of potent polymeric QACs (e.g. cationic poly (vinyl 
pyrdines),63 cationic poly (ethylene imines),64, 65 cationic chitosan66 and 
cationic polycarbonates67, 68) have been synthesized for antibacterial 
applications. These polymers are very potent antibacterial agents, but could 
potentially be cytotoxic and cause hemolysis. Immobilizing these polymeric 
QACs onto surfaces as non-leaching coatings could reduce their toxicity. The 
immobilization can be carried out by either “grafting to” or “grafting from” as 
shown in Figure 1.4.69 In the “grafting to” approach, diblock copolymers are 
typically used for physical adsorption with one component adhering to surface 
and the other component extending out from surface (Figure 1.4 (A)). 
Polymers with reactive end groups can also be covalently immobilized onto 
pre-functionalized surfaces using “grafting to” approach (Figure 1.4 (B)). In 
the “grafting from” approach, surfaces are first functionalized with an initiator, 
and then polymerization is directly initiated from surfaces when the surfaces 
are exposed to a monomer solution. (Figure 1.4 (C)). When comparing the two 
approaches, “grafting to” approach is the more straightforward approach while 
“grafting from” approach allows better control on coating thickness, 
composition and architecture.     




Figure 1.4 Two approaches (“grafting to” and “grafting from”) to immobilize 
polymeric QACs. (A) Physical adsorption of diblock copolymer on surface 
(“grafting to” approach); (B) grafting of polymers with functional group on 
modified surface (“grafting to” approach); (C) polymer brushes grown via 
surface-initiated polymerization (“grafting from” approach). (Reprinted with 
permission from Ref. 69 )  
Pioneering works to immobilize the polymeric QACs on surfaces were 
first carried out by Klibanov et.al.64, 70, 71 As a typical example, polyethylene 
imine (PEI) was immobilized on glass slides by reacting the amine groups of 
PEI with the alkylbromides on the functionalized surface. Then the remaining 
amine groups were quaternized by alkylation with alkyl halides. Later on, 
cationic PEI was applied as coatings on glass slide through a one-step dipping 
process.72 Although these polymeric QACs were physically adsorbed on the 
surfaces, they could be considered as immobilized since they were virtually 
insoluble in water after alkylation. Similar to covalently immobilized 
counterparts, these noncovalently immobilized polymeric QACs with an 
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optimized structure, exhibited excellent antibacterial activity against S. aureus 
and E. coli with 100% killing efficiency. This study showed that alkyl chain 
length of the polymers was important for the potency of the coatings. In 
addition to PEI coating, other polymeric QACs like cationic polyacrylate,73 
cationic poly (vinyl pyridine)70 and cationic biguanides74 have also been 
covalently immobilized onto surfaces and have been shown to possess good 
antibacterial activities. However, current approaches for covalent 
immobilization of polymeric QACs usually require multi-step treatments 
(activating surfaces, introducing functional group or spacer, grafting or 
growing polymer, and quaternization), hence increasing the production cost of 
the coatings. In addition, for polymeric QACs coatings, both physical 
adsorption and chemical bonding use various organic solvents, which could 
affect the overall integrity of polymeric substrates. For example, a very recent 
study has reported that soaking with ethanol can lead to polymer elution from 
catheter materials (e.g. polyurethane and silicone rubber) and resulted in 
various adverse effects like plasma protein precipitation and thrombosis.20   
In summary, many antibacterial coatings, including coatings delivering 
antibacterial agents and coatings with immobilized antibacterial agents, have 
been explored to prevent MDAIs. However, ideal antibacterial coatings should 
be produced in a facile and inexpensive process, and are able to kill bacteria, 
while maintain good stability and biocompatibility. Unfortunately, current 
approaches still do not meet all these requirements. Effective, facile and 
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inexpensive methods to coat the antibacterial agents on medical devices 
without inducing toxicity and drug-resistant bacteria are urgently required.  
1.4 Antifouling coatings 
Antibacterial coatings are a promising approach for prevention of CAIs, 
but biofouling is not only limited to bacterial cells, but also to other 
components such as proteins when catheters are exposed to blood fluid. A 
layer of proteins is adsorbed on the device surfaces within a few seconds in 
blood, and this protein layer acts like a conditioning film which facilitates the 
attachment of bacterial cells. Therefore, it is necessary to confer antifouling 
property in addition to antibacterial activity on catheter surfaces in order to 
obtain an effective anti-infective coating. A common method to obtain an 
antifouling coating is to immobilize antifouling polymers on the device 
surface. Poly (ethylene glycol) (PEG) or poly (ethylene oxide) (PEO) based 
polymers and zwitterioinic polymers have been widely employed as 
antifouling coatings.   
1.4.1 PEG-based antifouling coatings 
PEG, a highly water soluble polymer with low toxicity is one of the most 
extensive studied antifouling polymers, and the antifouling effects of 
PEG-based coating has been reported since 25 years ago.75-79. Although the 
exact mechanism by which PEG layers resist non-specific protein adsorption 
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remains in debate, it is generally accepted that the high mobility and large 
exclusion volume of PEG chains can be the main reasons responsible for their 
antifouling activity.77, 80, 81 When proteins or bacteria approach the PEG 
molecules, compression of the PEG chains results in repulsive elastic forces, 
and the removal of water from hydrated PEG chains creates an unfavourable 
osmotic penalty. These elastic forces and osmotic stresses perform as repulsive 
forces to prevent protein adsorption and bacterial adhesion on the surfaces.77, 
82 Grunze and co-workers found that self-assembly monolayer (SAM) of oligo 
(ethylene glycol) with helical conformation is better than trans conformation 
in regards to preventing protein adsorption, and suggested that the hydration of 
surfaces played a very important role in resisting protein adsorption.83 SAMs 
of PEG or oligo (ethylene glycol) are by far the best known antifouling system 
with a well-defined structure, complete coverage and easy fabrication, 
providing insight into antifouling mechanisms. However, the instability of 
SAMs in air and water due to competitive adsorption and thiol oxidation limits 
their applications as commercial antifouling coatings.84, 85. Apart from SAM, 
PEG molecules can be physically adsorbed86-88 or chemically grafted89-91 on 
the surfaces using “grafting to” or “grafting from” approaches.  
“Grafting to” approach was applied to fabricate PEG-based coatings via 
physical adsorption of diblock copolymers like PEO-polystyrene block 
polymers.92, 93. In these studies, polystyrene acted as the anchoring block while 
PEO extended out from the surfaces as the antifouling unit, and the adsorbed 
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amount of polymer can be varied by modulating the ratio of the PEO and 
polystyrene blocks. This technique is very suitable to coat surfaces with large 
areas or various shapes, but physical adsorption of PEG-based coatings has 
obvious limitations. Firstly, grafting density of polymer chains is low. When 
the surface is covered with polymer chains to the extent that the polymers 
begin to interweave, the adsorption process dramatically slows down as 
polymer chains have to overcome the repulsive barrier to contact with the 
surface. Secondly, it is necessary to choose a solvent which can dissolve both 
PEG and the other block, because the polymer tends to form micelles if only 
one block is dissolved in the chosen solvent, resulting in inhomogeneous 
coatings and decreased mobility.81 Finally, the instability is also an issue since 
adsorbed polymer could be eluted and be replaced by other molecules in the 
complex biological environment. Therefore, most antifouling coatings were 
fabricated by chemical grafting of pre-formed polymers and surface initiated 
polymerization.  
The chemical adsorption is able to produce polymer coatings with higher 
density and better stability. However, it is necessary to modify the surfaces via 
wet chemistry, plasma or UVO treatment before chemical grafting. Park and 
co-workers modified polyurethane (PU) with PEG1k (Mw=1,000) carrying 
terminal hydroxyl, amino and sulfonate groups and PEG3.4k (Mw=3,400) and 
PEG3.4k-heparin, but the PU surfaces had to be first grafted with 
hexamethylene diisocyanate through an allophanate reaction between the 
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urethane proton and the isocyanate.94 The free isocyanate groups on the PU 
surfaces then reacted with the functional group (-OH or -NH2) on PEG 
through a condensation reaction. As an alternative, plasma such as silicon 
tetrachloride (SiCl4) plasma was used to treat polyamide and polyester, and 
followed by immobilization of PEG through reaction between –OH group in 
PEG and Si-Cl on surfaces.95 Aldehyde plasma has also been used to treat 
surfaces (silicon wafers, optical waveguide chips, and perfluorinated 
ethylene-co-propylene polymer substrates), and poly (L-lysine)-g-PEG 
copolymers were then covalently immobilized on these plasma -modified 
surfaces via reductive amination between the amine groups of the PLL 
backbone with the aldehyde groups on the plasma-deposited interlayer.96 This 
PEG-based coatings created via chemical adsorption are more stable than their 
physically adsorbed counterparts. 
  The different grafting methods of PEG/PEO result in different grafting 
densities and chain conformations, which determine the anti-adhesive efficacy 
of PEG coatings. PEO chains with three separate molecular weights of 526, 
2,000 or 9,800 Da were grafted on glass surfaces by Roosjen and co-workers 
to study the effects of PEO chain length and grafting density on antifouling 
activity.97, 98 They found that different molecular weights resulted in different 
chain lengths from 2.8 to 23.7 nm, and chain grafting density from 2.3 to 0.2 
chains/nm2. The increase of chain length led to decreased initial deposition 
rates and lowered the number of adhering bacterial cells (S. epidermidis and P. 
                                                                    
22 
 
aeruginosa), however a smaller reduction of the more hydrophobic P. 
aeruginosa strain over the more hydrophilic S. epidermidis was observed. In 
addition, the reduction was less for the larger yeast cells (C. albicans and C. 
tropicalis) as compared to the smaller bacteria, and the authors suggested that 
decreased Lifshitz–van der Waals attraction may be responsible for the 
observed suppression of the microbial adhesion. 
With “grafting from” approach, applied through surface-initiated 
polymerization, PEG-based coatings have been prepared and allow better 
control of brush thickness and density. An antifouling coating with poly 
(ethylene glycol methacrylate) (PEGMA) brushes was prepared by 
surface-initiated atom transfer radical polymerization (ATRP) from glass or 
silicon oxide substrates.99 Apart from PEG-based brushes, other polymers such 
as zwitterionic polymers, have also been grafted on surfaces via “grafting from” 
approach.    
1.4.2 Zwitterionic polymer coatings and other antifouling coatings 
Zwitterionic polymers are polymers with an equal number of anionic and 
cationic groups along their polymer chains.100, 101 This combination of 
oppositely charged moieties makes the polymers ultra-hydrophilic with overall 
neutral charge. As the second most popular non-biofouling polymer apart from 
the PEG/PEO, zwitterionic polymers have been applied as coatings to prevent 
protein adsorption and bacterial adhesion. For the first time, Whitesides and 
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co-workers reported that zwitterionic SAMs composed of thiols terminating in 
N,N-dimethyl-amino-propane-1-sulfonic acid (-N+CH3)2CH2CH2CH2SO3-) 
groups were effective at resisting the adsorption of fibrinogen and 
lysozymes.102 In addition, Jiang and co-workers have shown that zwitterionic 
poly (sulfobetaine methacrylate) (PSBMA) could be grafted on gold surfaces 
via surface-initiated ATRP from SAMs of ω-mercaptoundecyl 
bromoisobutyrate, and this polymer coating was able to prevent bacterial 
adhesion and biofilm formation.103, 104 Another zwitterionic polymer, poly 
(carboxybetaine methacrylate) (PCBMA), has also been grafted on glass 
surfaces via ATRP by the same group. They found that PCBMA was 
comparable to PSBMA in resisting biofilm formation, as the amount of P. 
aeruginosa was reduced by 93% for 64 h. The advantages of using 
zwitterionic polymers as antifouling coatings over PEG-based coating are the 
chemical diversity of zwitterionic polymers.101 While PEG polymers share the 
same repeating unit, a broad spectrum of polymers with different monomers 
and chemical structures can be synthesized to form zwitterionic polymers. In 
addition, zwitterionic polymers allow different ionic groups to be incorporated 
into polymer. For example, carboxylate, sulfonate, or phosphate can act as 
anionic groups, and quaternary ammonium, phosphonium, pyridinium, or 
imidazolium can act as cationic groups. And this diversity could bring more 
functions to zwitterionic materials in addition to antifouling properties. For 
example, anionic antibacterial molecules and antibiotics have been 
                                                                    
24 
 
incorporated into zwitterionic polymer precursors either as a counterion of 
positively charged zwitterionic ester precursors or a building block attached to 
carboxylate group in the precursors through an easily hydrolysable ester 
bond.105, 106 When the antibacterial agents or antibiotics were released from the 
above systems, bacterial cells in the surrounding environment could be 
successfully inhibited and the polymer matrix left behind became zwitterioinic 
acting as an antifouling coating.  
In addition to coating of zwitterionic polymers, a few other hydrophilic 
polymer brushes have also been explored as possible antifouling coatings. For 
example, polyacrylamide (PAAm) brushes were coated on silicon rubber 
surfaces via surface-initiated ATRP using three steps: immobilization of a 
coupling agent (γ–aminopropyltriethoxysilane), anchoring of an ATRP 
initiator (4-(chloromethyl) benzoyl chloride), and polymerization of 
acrylamide.107 The PAAm brush coatings were effective against protein 
adsorption and reduced the adhesion of S. aureus by 58%, S. salivarius by 52% 
and C. albicans by 77%. Poly (methacrylic acid) is another polymer brush 
used as an antifouling coating on titanium surfaces. This coating is fabricated 
by immobilization of chlorosiliane as ATRP initiator and subsequent 
surface-initiated polymerization of methacrylic acid sodium salt. The resultant 
hydrophilic surfaces reduced bacterial adhesion (S. aureus and S. epidermidis) 
by 90%. 
In summary, various methods have been applied to immobilize 
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antifouling polymers (PEO/PEG, zwitterionic polymers and other hydrophilic 
polymers) to prevent protein adsorption and bacterial adhesion. PEO/PEG 
based polymer coatings are currently the most popular ones with excellent 
antifouling performance against various proteins and bacteria. This is probably 
due to the wide availability of PEG and its long history as a classical 
antifouling polymer. However, traditional approaches to graft PEO/PEG on 
surfaces have been typically instable (physical adsorption or SAM) or 
involved multiple steps and usage of different organic solvent (chemical 
immobilization). These issues can be neglected for theoretical studies, but they 
could limit the applications of PEG as medical device coatings to prevent 
infections in clinical settings. Dopamine/polydopamine (PDA) coatings which 
will be reviewed in the following section, may provide a good option for 
grafting of PEO/PEG based polymers in a facile manner.        
1.5 Mussel-inspired adhesive coatings using dopamine/polydoamine 
(PDA)  
The most common materials used in catheters are polymers such as 
silicone rubber and polyurethane, which are very hydrophobic and relatively 
inert. Therefore, it is difficult to coat these catheter materials with hydrophilic 
cationic polymer and PEG in aqueous solution. Normally, wet chemistry, 
ultraviolet-ozone (UVO) and plasma are usually applied to treat the inert 
polymeric materials before further functionalization or coating with 
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hydrophilic polymers. However, these pretreatments could alter the 
mechanical properties of treated materials or may require sophisticated 
instrument, complicating their usage in treating catheters. Therefore, a facile 
method is needed to activate inert catheter surfaces or an adhesive moiety 
should be conjugated in a polymer chain to facilitate the adhesion of the 
polymer to inert catheter surfaces.  . 
 
Scheme 1.1 Proposed mechanism of PDA formation by self-polymerization of 
dopamine. (Reprinted with permission from Ref.108 ) 
 
Dopamine is a molecule containing amine and catechol functional groups. 
This biomolecules has been found to be abundant in mussel adhesive 
proteins.109 Subjected to a slightly basic condition, dopamine can 
self-polymerize to form thin adherent polydopamine (PDA) films on a variety 
of material surfaces.110 Both organic and inorganic substrates can be well 
covered by PDA coatings, including well-known non-sticky poly 
(tetrafluoroethylene) (PTFE) surfaces. Up until now, the exact structure of 
PDA and its polymerization mechanisms are still unknown, but it was 
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proposed that the polymerization of dopamine could follow similar reaction 
pathways to the eumelanin synthesis as shown in Scheme 1.1.108, 111 Recently, 
Dreyer and co-workers have proposed that PDA could be not a covalent 
polymer but instead a supermolecular aggregate of monomers 
(5,6-dihydroxyindoline and its dione derivative) that are held together through 
a combination of charge transfer, π- stacking, and hydrogen bonding 
interactions.112 No matter which mechanism is correct, it is generally accepted 
that the final product PDA is a catechol-rich polymer, and these catechol 
groups are mainly responsible for the adhesion of the polymer network to 
various solid surfaces.108 The interaction between PDA and substrates involves 
covalent binding when the substrates contain amine or thiol groups, which 
react with catechol group in PDA via Michael addition and/or Schiff base 
reaction (Figure 1.5). Other non-covalent interactions such as metal 
coordination or chelating, hydrogen bonding and - stacking are responsible 
for the adhesive properties of PDA on other surfaces without amines or 
thiols.113 Although the exact formation of PDA and mechanisms of its 
adhesive property are still under investigation, PDA coatings have been 
extensively explored in various biomedical applications.  




Figure 1.5 Possible reactions between oxidized catechols and amines, thiols or 
imidazoles. (Reprinted with permission from Ref.108) 
 
To act as a biomaterial, the biocompatibility of PDA is extremely 
important. The PDA coatings have been reported to be able to promote the 
adhesion of many types of mammalian cells (fibroblasts, neurons, osteoblasts 
and endothelial cells) and enhance their viability on various surfaces, 
including anti-adhesive ePTFE surfaces.113-117 A recent study showed that PDA 
nanoparticles induced no obvious cytotoxicity when in contact with mouse 
breast cancer cells and human cervical cancer cells even at a relatively high 
dose. In vivo studies have also shown that PDA nanoparticles have a high 
median lethal dose (LD50) up to 483.95 mg/kg, indicating low acute toxicity of 
PDA nanoparticles. In addition, the injection of PDA nanoparticles resulted in 
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no detectable interference in the physiological regulation of immune 
response.118 These reports provide strong evidence for the negligible 
cytotoxicity of PDA.    
As an emerging platform of surface functionalization, PDA film 
depositing on surfaces can be further functionalized with proteins, peptides, 
oligonucleotides and synthetic polymers through the reaction of thiol or amine 
functional groups with catechol/quinone groups in PDA via Michael addition 
and/or Schiff-base reactions as show in Figure 1.6.108, 110 This strategy has also 
been used to coat antibacterial and antifouling agents on various surfaces. Lee 
and co-workers grafted thiol-terminated methoxy-poly (ethylene glycol) 
(mPEG-SH) to PDA-coated substrates, and these modified surfaces exhibited 
antifouling property against mammalian cells lasting up to two days.110 The 
same group functionalized polycarbonate substrates with PDA and followed 
by deposition of silver nanoparticles and subsequent grafting of PEG as 
antibacterial and antifouling coatings. The modified surfaces could not only 
kill both Gram-positive and Gram-negative bacteria strains due to the release 
of silver from the coatings, but also inhibit their attachment on the substrate.119 
In addition, silver nanoparticles were found to be uniformly coated on 
PDA-modified graphene nanosheets instead forming aggregates, and the 
coatings exhibited antibacterial activity against both Gram-positive and 
Gram-negative bacteria at the low concentration of 1% (v/v).120 To avoid 
leaching of antibacterial agents from surfaces, antimicrobial carboxymethyl 
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chitosan (CMCS) has also been grafted to silicone surface which had been 
pre-treated with PDA, via the reaction with amino group in CMCS.121 These 
polymer grafted surfaces displayed excellent anti-adhesion properties against 
E. coli and P. mirabilis, and prevented biofilm formation under flow 
condition..  
As another facile strategy to functionalize surfaces, polymers with 
dopamine or 3,4-dihydroxyphenylalanine (DOPA) residues were found to be 
able to coat on various surfaces by using a simple dip-coating procedure.122-125 
For the first time, Messersmith and co-workers synthesized the polymer 
(mPEG-DOPA) by conjugating monomethoxy-terminated PEG to a 
3,4-dihydroxyphenylalanine (DOPA), which is an important component of the 
mussel adhesive protein, and coated this mPEG-DOPA on titanium surfaces as 
antifouling agent via the use of one-step dipping.125, 126 This mPEG-DOPA 
coating on Au surfaces prevented protein adsorption and the adhesion of 
fibroblasts effectively. In addition, this mPEG-DOPA with three DOPA 
residues resulted in higher densities than that obtained by using several other 
approaches to immobilize PEG. Apart from the incorporation of dopamine in 
antifouling polymers, dopamine and its analogues have also been conjugated 
into antibacterial polymers. For example, Kuroda and co-workers synthesized 
amphiphilic polycations with different molar ratios of monomers including 
dodecyl quaternary ammonium, catechol groups and methoxyethyl, and coated 
the polymers on glass slides by dip coating.122 The catechol group allowed for 
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the immobilization of the polymer to substrates and quaternary ammonium 
acted as antibacterial block, while methoxyethyl side chain was used to tune 
hydrophobic/hydrophilic balance. The polymer-coated surfaces exhibited 
antibacterial activity against S. aureus and E. coli, and prevented the 
accumulation of viable bacteria for up to 96 h. However, the coatings with 
aforementioned polymers containing dopamine or its analogues were 
fabricated in organic solvents, which could be a potential problem for further 
application as catheter coatings. In addition, only metal and glass substrates, 
which are relatively active for catechol groups, were tested. The adhesive 
properties of these polymers on inert polymeric substrates in organic solvents 
have not been examined, which could be an issue, because dopamine and its 
analogue in these polymers cannot form cross-linked PDA-like network in 
organic solvents, but this network could be necessary to enhance the adhesive 
properties.         
1.6 Gaps, objectives and scope 
In previous sections, various approaches to modifying surfaces in order to 
prevent MDAIs and CAIs have been reviewed. Antibacterial and antifouling 
coatings as two of the more promising approaches were highlighted. 
Unfortunately, current approaches can barely meet the requirements for 
clinical application of medical devices. The gaps for the current studies of 
surface modification are summarized below:  
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Although antibiotics or silver coated surfaces are most commonly 
investigated and show excellent antibacterial activity, they have their own 
disadvantages. Overdose of antibiotics could lead to the emergence of more 
drug-resistant bacteria, and toxicity of silver is a major issue for a more 
widespread application of silver-coated surfaces. In addition, to load a large 
amount of antibiotics or silver onto device surface, complex, labor- and 
time-consuming techniques, such as the layer-by-layer technique, are required. 
These techniques could greatly increase the cost of medical devices like 
catheters. 
Various polymers like polymeric QACs or PEG can be coated on medical 
device surfaces to generate an antibacterial or antifouling surface, but multiple 
steps including surfaces activation, functionalization and grafting are required. 
In addition, organic solvent is typically inevitable for polymer brush coatings, 
which may affect the integrity of catheter materials. The complicated 
procedure and usage of organic solvents make the application of these 
polymer coatings quite difficult.  
Despite the great popularity and effectiveness of antibacterial and 
antifouling coatings, there are fundamental limitations to both approaches. 
Antibacterial surfaces can possess poor biocompatibility and may lead to the 
accumulation of dead bacteria or proteins on the surface, resulting in reduced 
surface antibacterial activity, while antifouling materials based on PEG or 
zwitterionic polymers could be ineffective under dry conditions or after 
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bacteria have adhered onto the surface due to their inability to kill bacteria. 
Therefore, an ideal anti-infective material should combine the strengths of 
both strategies to kill bacteria and simultaneously prevent the fouling of 
protein and bacteria on the surface. In addition, this ideal material should also 
be able to be coated on various surfaces through a facile and non-toxic 
approach.   
 
Scheme 1.2 The main aim of this thesis and the coating strategies applied in 
this study. 
The main aim of this study was to propose several facile and effective 
anti-infective coating strategies by combining antibacterial QACs, antifouling 
PEG and adhesive dopamine/PDA to prevent CAIs. The other aim of this 
study was to examine the interactions between the surfaces coated with 
polymers with antibacterial, antifouling and adhesive moieties and bacteria, by 
changing polymer composition and coating condition. It is hypothesized that 
the polymers with antibacterial and antifouling moieties can be easily coated 
on inert catheter surfaces with the assistance of PDA as an intermediate layer 
or with the incorporation of dopamine in polymers. In addition, the 
antibacterial and antifouling moieties in the polymer will have synergetic 
effects allowing for complete inhibition of bacterial adhesion and subsequent 
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biofilm formation. Moreover, these polymer coatings should have good 
biocompatibility due to the presence of PEG and non-toxic dopamine. To 
assess the hypothesis, the following studies were carried out: 
In Chapter 2, a series of diblock copolymers of PEG and cationic 
polycarbonates with various compositions were synthesized by metal-free 
organocatalytic ring-opening polymerization, and coated onto silicone rubber 
using a thin film of reactive PDA as an intermediate layer. The antibacterial 
and antifouling activities against S. aureus including methicillin-resistant S. 
aureus (MRSA), and hemocompatibility (hemolysis, protein adsorption and 
platelet adhesion) were examined. 
In Chapter 3, a hydrogel system with antimicrobial polycarbonates and 
PEG networks via Michael addition chemistry was further designed and the 
hydrogel was coated on catheter materials with the assistance of an 
intermediate PDA thin layer. Antibacterial and antifouling activities against 
both Gram-positive and Gram-negative bacteria were assessed.    
In Chapter 4, polymers containing antibacterial cations, antifouling PEG 
and adhesive dopamine were synthesized. By optimizing the polymer 
composition and coating condition, the polymers were readily coated onto the 
catheter surface through a one-step process and the coating mechanism was 
studied. The antibacterial and antifouling activities against S. epidermidis, S. 
aureus and E. coli as well as stability and hemocompatibility were evaluated.  
This thesis will focus on effective strategies to generate antibacterial and 
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antifouling coatings on medical device surfaces using various polymers, and 
study of their antibacterial and antifouling activities against both 
Gram-positive and Gram-negative bacteria in vitro. In vivo studies of these 
coating systems were not considered due to limited availability of animal 
infection models as well as insufficient time available.  
1.7 References           
1. H. J. Busscher, H. C. van der Mei, G. Subbiahdoss, P. C. Jutte, J. J. A. 
M. van den Dungen, S. A. J. Zaat, M. J. Schultz and D. W. Grainger, 
Sci. Transl. Med., 2012, 4, 153rv110. 
2. W. Zimmerli, A. Trampuz and P. E. Ochsner, N. Engl. J. Med., 2004, 
351, 1645-1654. 
3. M. W. Harding, L. L. Marques, R. J. Howard and M. E. Olson, Trends 
Microbiol., 2009, 17, 475-480.. 
4. D. Davies, Nat. Rev. Drug Discov., 2003, 2, 114-122. 
5. E. Woods and S. L. Percival, Biofilms in Infection Prevention and 
Control: A Healthcare Handbook, 2014, 185. 
6. R. M. Donlan, Emerg. Infect. Dis., 2001, 7, 277. 
7. S. Hugonnet, H. Sax, P. Eggimann, J.-C. Chevrolet and D. Pittet, 
Emerg. Infect. Dis., 2004, 10, 76. 
8. D. Frasca, C. Dahyot-Fizelier and O. Mimoz, Crit. Care, 14, 212. 
9. L. A. Mermel, Ann. Intern. Med., 2000, 132, 391-402. 
                                                                    
36 
 
10. N. P. O'Grady, M. Alexander, L. A. Burns, E. P. Dellinger, J. Garland, S. 
O. Heard, P. A. Lipsett, H. Masur, L. A. Mermel, M. L. Pearson, I. I. 
Raad, A. G. Randolph, M. E. Rupp, S. Saint and t. H. I. C. P. A. 
Committee, Clin. Infect. Dis., 2011, 52, 162-193. 
11. R. A. Weinstein and R. O. Darouiche, Clin. Infect. Dis., 2001, 33, 
1567-1572. 
12. E. M. Hetrick and M. H. Schoenfisch, Chem. Soc. Rev., 2006, 35, 
780-789. 
13. A. W. Smith, Adv. Drug Del. Rev., 2005, 57, 1539-1550. 
14. L. Hall-Stoodley, J. W. Costerton and P. Stoodley, Nat. Rev. Immunol., 
2004, 2, 95-108. 
15. F. Moriarty, S. A. J. Zaat and H. J. Busscher, eds., Biomaterials 
Associated Infection, Springer, New York, 2013. 
16. M. Samore and J. Burke, Curr. Clin. Top. Infect. Dis., 2000, 20, 256. 
17. A. Sitges-Serra and M. Girvent, World J. Surg., 1999, 23, 589-595. 
18. N. P. O'Grady, M. Alexander, E. P. Dellinger, J. L. Gerberding, S. O. 
Heard, D. G. Maki, H. Masur, R. D. McCormick, L. A. Mermel, M. L. 
Pearson, I. I. Raad, A. Randolph and R. A. Weinstein, Clin. Infect. Dis., 
2002, 35, 1281-1307. 
19. D. Shaffer, Am. J. Kidney Dis., 1995, 25, 593-596. 
20. L. A. Mermel and N. Alang, J. Antimicrob. Chemother., 2014, dku182. 
21. D. C. Gough NL, Food control, 1998, 6, 363-368. 
                                                                    
37 
 
22. M. A. Assanta., D. Roy, and D. Monpetit, J. Food Prot., 1998. 
23. S. C. Veiga AS, Gaspar D, Franquelim HG, Castanho MA, Schneider 
JP, Biomaterials, 2012, 33, 8907-8916. 
24. C. P. Zhang W, Ji J, Zhang Y, LIu Z, Fu RK, Biomaterials, 2006, 27, 
44-51. 
25. K. S. Martin TP, Chang SH, Sedransk KL, Gleason KK, Biomaterials, 
2007, 6, 905-915. 
26. D. Campoccia, L. Montanaro and C. R. Arciola, Biomaterials, 2013, 34, 
8533-8554. 
27. M. Stigter, J. Bezemer, K. de Groot and P. Layrolle, J. Controlled 
Release, 2004, 99, 127-137. 
28. M. A. Rauschmann, T. A. Wichelhaus, V. Stirnal, E. Dingeldein, L. 
Zichner, R. Schnettler and V. Alt, Biomaterials, 2005, 26, 2677-2684. 
29. M. Zilberman and J. J. Elsner, J. Controlled Release, 2008, 130, 
202-215. 
30. J. Min, R. D. Braatz and P. T. Hammond, Biomaterials, 2014, 35, 
2507-2517. 
31. F. Wu, G. Meng, J. He, Y. Wu and Z. Gu, ACS Appl. Mater. Interfaces, 
2014. 
32. B.-S. Kim, S. W. Park and P. T. Hammond, Acs Nano, 2008, 2, 
386-392. 
33. A. L. Casey, L. A. Mermel, P. Nightingale and T. S. Elliott, Lancet 
                                                                    
38 
 
Infect. Dis., 2008, 8, 763-776. 
34. Z.-m. Xiu, Q.-b. Zhang, H. L. Puppala, V. L. Colvin and P. J. J. Alvarez, 
Nano Lett., 2012, 12, 4271-4275. 
35. P. V. AshaRani, , G. L. K. Mun, M. P. Hande, and S. Valiyaveettil, ACS 
Nano 2008, 3, 279-290. 
36. C.-N. Lok, C.-M. Ho, R. Chen, Q.-Y. He, W.-Y. Yu, H. Sun, P. K.-H. 
Tam, J.-F. Chiu and C.-M. Che, J. Proteome Res., 2006, 5, 916-924. 
37. M. -J, Catalina, E. M. V. Hoek, J Nanopart Res, 2010, 12, 1531-1551. 
38. K. Vasilev, V.Sah, K. Anselme, C. Ndi, M. Mateescu, B. Dollmann, P. 
Martinek, L. Ploux, and H. J. Griesser, Nano letters, 2009, 10, 
202-207. 
39. S. Sánchez‐Valdes, H. Ortega‐Ortiz, L. Ramos‐de Valle, F. 
Medellín‐Rodríguez and R. Guedea‐Miranda, J. Appl. Polym. Sci., 
2009, 111, 953-962. 
40. T. Galya, V. Sedlařík, I. Kuřitka, R. Novotný, J. Sedlaříková and P. 
Sáha, J. Appl. Polym. Sci., 2008, 110, 3178-3185. 
41. W. Chen, Y. Liu, H. S. Courtney, M. Bettenga, C. M. Agrawal, J. D. 
Bumgardner, and J. L. Ong, Biomaterials, 2006, 27, 5512-5517. 
42. K. N. Stevens, O. Crespo-Biel, E. E. van den Bosch, A. A. Dias, M. L. 
Knetsch, Y. B. Aldenhoff, F. H. van der Veen, J. G. Maessen, E. E. 
Stobberingh and L. H. Koole, Biomaterials, 2009, 30, 3682-3690. 
43. S. Kwok, W. Zhang, G. Wan, D. McKenzie, M. Bilek and P. K. Chu, 
                                                                    
39 
 
Diamond Relat. Mater., 2007, 16, 1353-1360. 
44. B. J. Nablo, H. L. Prichard, R. D. Butler, B. Klitzman and M. H. 
Schoenfisch, Biomaterials, 2005, 26, 6984-6990. 
45. W. Cai, J. Wu, C. Xi, A. J. Ashe Iii and M. E. Meyerhoff, Biomaterials, 
2011, 32, 7774-7784. 
46. V. Antoci Jr, C. S. Adams, J. Parvizi, P. Ducheyne, I. M. Shapiro and N. 
J. Hickok, Clin. Orthop., 2007, 461, 81-87. 
47. N. Aumsuwan, S. Heinhorst and M. W. Urban, Biomacromolecules, 
2007, 8, 713-718. 
48. N. Aumsuwan, R. C. Danyus, S. Heinhorst and M. W. Urban, 
Biomacromolecules, 2008, 9, 1712-1718. 
49. F. Costa, I. F. Carvalho, R. C. Montelaro, P. Gomes and M. C. L. 
Martins, Acta Biomater., 2011, 7, 1431-1440. 
50. E. Guaní-Guerra, T. Santos-Mendoza, S. O. Lugo-Reyes and L. M. 
Terán, Clin. Immunol., 2010, 135, 1-11. 
51. M. Pushpanathan, P. Gunasekaran and J. Rajendhran, Int. J. Pept., 
2013, 2013, 15. 
52. A. C. Engler, N. Wiradharma, Z. Y. Ong, D. J. Coady, J. L. Hedrick 
and Y.-Y. Yang, Nano Today, 2012, 7, 201-222. 
53. N. Wiradharma, U. Khoe, C. A. E. Hauser, S. V. Seow, S. Zhang and 
Y.-Y. Yang, Biomaterials, 2011, 32, 2204-2212. 
54. R. Chen, N. Cole, M. D. Willcox, J. Park, R. Rasul, E. Carter and N. 
                                                                    
40 
 
Kumar, Biofouling, 2009, 25, 517-524. 
55. M. Gabriel, K. Nazmi, E. C. Veerman, A. V. Nieuw Amerongen and A. 
Zentner, Bioconjugate Chem., 2006, 17, 548-550. 
56. M. D. Steven and J. H. Hotchkiss, J. Appl. Polym. Sci., 2008, 110, 
2665-2670. 
57. M. Willcox, E. Hume, Y. Aliwarga, N. Kumar and N. Cole, J. Appl. 
Microbiol., 2008, 105, 1817-1825. 
58. K. Glinel, A. M. Jonas, T. Jouenne, J. Leprince, L. Galas and W. T. 
Huck, Bioconjugate Chem., 2008, 20, 71-77. 
59. C. J. Waschinski, V. Herdes, F. Schueler and J. C. Tiller, Macromol. 
Biosci., 2005, 5, 149-156. 
60. V. Norris, M. Chen, M. Goldberg, J. Voskuil, G. McGurk and B. 
Holland, Mol. Microbiol., 1991, 5, 775-778. 
61. C. Z. Chen and S. L. Cooper, Biomaterials, 2002, 23, 3359-3368. 
62. M. Zasloff, Nature, 2002, 415, 389-395. 
63. Z. Cheng, X. Zhu, Z. Shi, K. Neoh and E. Kang, Ind. Eng. Chem. Res., 
2005, 44, 7098-7104. 
64. J. Lin, S. Qiu, K. Lewis and A. M. Klibanov, Biotechnol. Bioeng., 2003, 
83, 168-172. 
65. T. P. Schaer, S. Stewart, B. B. Hsu and A. M. Klibanov, Biomaterials, 
2012, 33, 1245-1254. 
66. N. Liu, X.-G. Chen, H.-J. Park, C.-G. Liu, C.-S. Liu, X.-H. Meng and 
                                                                    
41 
 
L.-J. Yu, Carbohydr. Polym., 2006, 64, 60-65. 
67. F. Nederberg, Y. Zhang, J. P. Tan, K. Xu, H. Wang, C. Yang, S. Gao, X. 
D. Guo, K. Fukushima and L. Li, Nat. Chem., 2011, 3, 409-414. 
68. Y. Qiao, C. Yang, D. J. Coady, Z. Y. Ong, J. L. Hedrick and Y.-Y. Yang, 
Biomaterials, 2012, 33, 1146-1153. 
69. R. Barbey, L. Lavanant, D. Paripovic, N. Schüwer, C. Sugnaux, S. 
Tugulu and H.-A. Klok, Chem. Rev., 2009, 109, 5437-5527. 
70. J. C. Tiller, C.-J. Liao, K. Lewis and A. M. Klibanov, Proc. Natl. Acad. 
Sci. U S A, 2001, 98, 5981-5985. 
71. J. Lin, S. Qiu, K. Lewis and A. M. Klibanov, Biotechnol. Progr., 2002, 
18, 1082-1086. 
72. D. Park, J. Wang and A. M. Klibanov, Biotechnol. Progr., 2006, 22, 
584-589. 
73. S. B. Lee, R. R. Koepsel, S. W. Morley, K. Matyjaszewski, Y. Sun and 
A. J. Russell, Biomacromolecules, 2004, 5, 877-882. 
74. S. P. Sawan, S. Subramanyam and A. Yurkovetskiy, Google Patents, 
2000. 
75. J. H. Lee, J. Kopecek and J. D. Andrade, J. Biomed. Mater. Res., 1989, 
23, 351-368. 
76. J. H. Lee, P. Kopeckova, J. Kopecek and J. D. Andrade, Biomaterials, 
1990, 11, 455-464. 
77. S. Jeon, J. Lee, J. Andrade and P. De Gennes, J. Colloid Interface Sci., 
                                                                    
42 
 
1991, 142, 149-158. 
78. K. L. Prime and G. M. Whitesides, J. Am. Chem. Soc., 1993, 115, 
10714-10721. 
79. H. Ma, J. Hyun, P. Stiller and A. Chilkoti, Adv. Mater., 2004, 16, 
338-341. 
80. J. M. Harris, Introduction to biotechnical and biomedical applications 
of poly (ethylene glycol), Springer, 1992. 
81. E. P. K. Currie, W. Norde and M. A. Cohen Stuart, Adv. Colloid 
Interface Sci., 2003, 100–102, 205-265. 
82. I. Banerjee, R. C. Pangule and R. S. Kane, Adv. Mater., 2011, 23, 
690-718. 
83. R. Wang, H. Kreuzer and M. Grunze, J. Phys. Chem. B, 1997, 101, 
9767-9773. 
84. M. Cerruti, S. Fissolo, C. Carraro, C. Ricciardi, A. Majumdar and R. 
Maboudian, Langmuir, 2008, 24, 10646-10653. 
85. A. Kanta, R. Sedev and J. Ralston, Colloids Surf. Physicochem. Eng. 
Aspects, 2006, 291, 51-58. 
86. V. A. Liu, W. E. Jastromb and S. N. Bhatia, J. Biomed. Mater. Res., 
2002, 60, 126-134. 
87. D. L. Elbert and J. A. Hubbell, J. Biomed. Mater. Res., 1998, 42, 55-65. 
88. G. L. Kenausis, J. Vörös, D. L. Elbert, N. Huang, R. Hofer, L. 
Ruiz-Taylor, M. Textor, J. A. Hubbell and N. D. Spencer, J. Phys. 
                                                                    
43 
 
Chem. B, 2000, 104, 3298-3309. 
89. N. Xia, Y. Hu, D. W. Grainger and D. G. Castner, Langmuir, 2002, 18, 
3255-3262. 
90. M. Amiji and K. Park, J. Biomater. Sci. Polym. Ed., 1993, 4, 217-234. 
91. P. Kingshott, J. Wei, D. Bagge-Ravn, N. Gadegaard and L. Gram, 
Langmuir, 2003, 19, 6912-6921. 
92. J. Marra and M. L. Hair, Colloids and Surfaces, 1989, 34, 215-226. 
93. H. D. Bijsterbosch, V. O. de Haan, A. W. de Graaf, M. Mellema, F. A. 
M. Leermakers, M. A. C. Stuart and A. A. v. Well, Langmuir, 1995, 11, 
4467-4473. 
94. K. D. Park, Y. S. Kim, D. K. Han, Y. H. Kim, E. H. B. Lee, H. Suh and 
K. S. Choi, Biomaterials, 1998, 19, 851-859. 
95. B. Dong, H. Jiang, S. Manolache, A. C. L. Wong and F. S. Denes, 
Langmuir, 2007, 23, 7306-7313. 
96. T. M. Blättler, S. Pasche, M. Textor and H. J. Griesser, Langmuir, 2006, 
22, 5760-5769. 
97. A. Roosjen, H. J. Kaper, H. C. van der Mei, W. Norde and H. J. 
Busscher, Microbiology, 2003, 149, 3239-3246. 
98. A. Roosjen, H. C. van der Mei, H. J. Busscher and W. Norde, 
Langmuir, 2004, 20, 10949-10955. 
99. S. Tugulu and H.-A. Klok, Biomacromolecules, 2008, 9, 906-912. 
100. A. B. Lowe and C. L. McCormick, Chem. Rev., 2002, 102, 4177-4190. 
                                                                    
44 
 
101. L. Mi and S. Jiang, Angew. Chem. Int. Ed., 2014, 53, 1746-1754. 
102. R. E. Holmlin, X. Chen, R. G. Chapman, S. Takayama and G. M. 
Whitesides, Langmuir, 2001, 17, 2841-2850. 
103. Z. Zhang, S. Chen, Y. Chang and S. Jiang, J. Phys. Chem. B, 2006, 110, 
10799-10804. 
104. G. Cheng, Z. Zhang, S. Chen, J. D. Bryers and S. Jiang, Biomaterials, 
2007, 28, 4192-4199. 
105. G. Cheng, H. Xue, G. Li and S. Jiang, Langmuir, 2010, 26, 
10425-10428. 
106. L. Mi and S. Jiang, Biomaterials, 2012, 33, 8928-8933. 
107. I. Fundeanu, H. C. van der Mei, A. J. Schouten and H. J. Busscher, 
Colloids Surf. B. Biointerfaces, 2008, 64, 297-301. 
108. E. Faure, C. Falentin-Daudré, C. Jérôme, J. Lyskawa, D. Fournier, P. 
Woisel and C. Detrembleur, Prog. Polym. Sci., 2013, 38, 236-270. 
109. J. H. Waite and X. Qin, Biochemistry (Mosc). 2001, 40, 2887-2893. 
110. H. Lee, S. M. Dellatore, W. M. Miller and P. B. Messersmith, Science, 
2007, 318, 426-430. 
111. E. Herlinger, R. F. Jameson and W. Linert, J. Chem. Soc., Perkin Trans. 
2, 1995, 259-263. 
112. D. R. Dreyer, D. J. Miller, B. D. Freeman, D. R. Paul and C. W. 
Bielawski, Langmuir, 2012, 28, 6428-6435. 
113. Y. Liu, K. Ai and L. Lu, Chem. Rev., 2014, 114, 5057-5115. 
                                                                    
45 
 
114. S. Hong, K. Y. Kim, H. J. Wook, S. Y. Park, K. D. Lee, D. Y. Lee and 
H. Lee, Nanomedicine, 6, 793-801. 
115. S. H. Ku and C. B. Park, Biomaterials, 2010, 31, 9431-9437. 
116. S. H. Ku, J. Ryu, S. K. Hong, H. Lee and C. B. Park, Biomaterials, 
2010, 31, 2535-2541. 
117. Z. Yang, Q. Tu, Y. Zhu, R. Luo, X. Li, Y. Xie, M. F. Maitz, J. Wang and 
N. Huang, Adv. Healthc. Mater., 2012, 1, 548-559. 
118. Y. Liu, K. Ai, J. Liu, M. Deng, Y. He and L. Lu, Adv. Mater., 2013, 25, 
1353-1359. 
119. T. S. Sileika, H.-D. Kim, P. Maniak and P. B. Messersmith, ACS Appl. 
Mater. Interfaces, 2011, 3, 4602-4610. 
120. Z. Zhang, J. Zhang, B. Zhang and J. Tang, Nanoscale, 2013, 5, 
118-123. 
121. R. Wang, K. G. Neoh, Z. Shi, E.-T. Kang, P. A. Tambyah and E. 
Chiong, Biotechnol. Bioeng., 2012, 109, 336-345. 
122. H. Han, J. Wu, C. W. Avery, M. Mizutani, X. Jiang, M. Kamigaito, Z. 
Chen, C. Xi and K. Kuroda, Langmuir, 2011, 27, 4010-4019. 
123. J. L. Dalsin, L. Lin, S. Tosatti, J. Voros, M. Textor and P. B. 
Messersmith, Langmuir, 2004, 21, 640-646. 
124. E. Faure, P. Lecomte, S. Lenoir, C. Vreuls, C. Van De Weerdt, C. 
Archambeau, J. Martial, C. Jerome, A.-S. Duwez and C. Detrembleur, 
J. Mater. Chem., 2011, 21, 7901-7904. 
                                                                    
46 
 
125. J. L. Dalsin, B.-H. Hu, B. P. Lee and P. B. Messersmith, J. Am. Chem. 
Soc., 2003, 125, 4253-4258. 
126. J. L. Dalsin, L. Lin, S. Tosatti, J. Vörös, M. Textor and P. B. 
Messersmith, Langmuir, 2004, 21, 640-646. 
 
                                                                    
47 
 
 Chapter 2. Antibacterial and Antifouling Catheter Coatings Using 
Surfaces Grafted with PEG-b-Cationic Polycarbonate Diblock 
Copolymers 
2.1 Background 
As reviewed in Chapter 1, catheter-associated infections (CAIs) have 
become one of the most common sources of healthcare-associated infections.1, 
2. Biofilm formation on catheters is the main cause for CAIs. Once a mature 
biofilm has been developed, the bacteria growing in the biofilm become highly 
resistant to both antimicrobial agents and the host immune response.3 
Coagulase-negative staphylococci are the most common causes of 
intravascular CAIs, followed by S. aureus, including methicillin-resistant S. 
aureus (MRSA).4, 5 The latter are more virulent and clinically significant, with 
infections causing greater morbidity and mortality compared to 
coagulase-negative staphylococci.  
Silicone rubber is an extensively used catheter material because of its 
flexibility, low toxicity and physiological inertness. However, microbes easily 
adhere to this material causing infections.6 Several strategies to modify the 
surface of silicone rubber to overcome this infection problem have been 
reported. For example, antibiotics (e.g. rifampin and minocycline) or silver 
have been coated onto catheter surfaces,7, 8 and these surface-coated catheters 
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do prevent bacterial adhesion and biofilm formation. However, the risk of 
bacterial resistance and their inadequate efficacy have hindered their use in 
clinical applications.1, 9 In another approach, polyacrylamide and poly 
(ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) triblock 
copolymer brushes were grafted from silicone rubber by polymerization from 
the surface through multiple steps,6, 10 which successfully precluded the 
adhesion of S. aureus, S. salivarius, S. epidermidis and C. albicans. However, 
the complexity of growing polymer brushes from the rubber surface may lead 
to difficulty in characterization and a large batch-to-batch variation in coating 
thickness and quality. Therefore, there is a pressing need to develop a 
non-toxic, facile and effective catheter coating for the prevention of CAIs.  
In this study, the aim is to coat diblock copolymers of poly (ethylene 
glycol) (PEG) and cationic antibacterial polycarbonate onto silicone rubber via 
a reactive polydopamine (PDA) layer to induce antibacterial and antifouling 
surfaces. Mussel-inspired PDA can form a thin layer on virtually all types of 
material surfaces by a simple immersion of the surfaces into a dopamine 
solution. Polymers can be grafted onto the PDA coating by reaction involving 
a polymer containing thiol or amine functional groups with catechol/quinone 
groups in PDA via Michael addition and/or Schiff-base reactions.11 For 
example, Lee and co-workers grafted thiol-terminated methoxy-poly (ethylene 
glycol) (mPEG-SH) to PDA-coated substrates, and these modified surfaces 
exhibited antifouling property against mammalian cells up to 2 days.11 PEG or 
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PEG-based coatings have been of great interest in the drive to develop 
antifouling surfaces.10, 12-14 However, the reduction in antifouling performance 
of PEG coatings over time could be a major issue.15   
Recently, a metal-free organocatalytic controlled/living ring-opening 
polymerization (ROP) method 16 to synthesize well defined polycarbonates 
with various functionalities for biomedical applications has been reported.17-21 
In particular, block and random cationic polycarbonates were synthesized with 
a broad spectrum of antibacterial activity and high selectivity towards 
microbial cells over mammalian cells. These antibacterial polycarbonates did 
not induce toxicity towards the major organs or blood of tested mice after i.v. 
injection.22, 23 In this study, thiol-terminated diblock copolymers of PEG and 
cationic polycarbonates (HS-PEG-CPC) with various compositions were 
synthesized. HS-PEG-CPC was then grafted onto the PDA-coated silicone 
rubber via the Michael addition between oxidized catechol group in PDA and 
thiol group in HS-PEG-CPC. The antibacterial and antifouling activities of 
these polymer coatings against both methicillin-susceptible S. aureus and 
MRSA which are the leading causes for CAIs 24 were systematically 
investigated. The effects of polymer compositions were studied. In addition, 
blood compatibility including blood protein adsorption, platelet adhesion and 
hemolysis of the coated surfaces were also examined.     
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2.2 Materials and methods 
2.2.1 Materials 
HS-PEG-OH (Mn 5000 g/mol, PDI 1.03) and CH3O-PEG-OH (also called 
as MPEG, Mn 5000 g/mol, PDI 1.05) were purchased from RAPP Polymere 
GmbH (Germany), which were freeze-dried and transferred to a glove-box at 
least one day prior to use. N-(3,5-trifluoromethyl)phenyl-N’-cyclohexyl 
-thiourea (TU) was prepared according to the literature procedure.25 TU was 
dissolved in dry THF, stirred with CaH2, filtered, and freed of solvent in vacuo. 
1,8-Diazabicyclo[5,4,0]undec-7-ene (DBU) was stirred over CaH2 and 
vacuum distilled before being transferred to a glove-box. All other chemical 
reagents such as dopamine hydrochloride and bovine serum albumin (BSA) 
were bought from Sigma-Aldrich and used as received unless otherwise 
mentioned. Silicone kit Sylgard 184 was purchased from Dow Corning and 
used according to the suggested protocols. A LIVE/DEAD Baclight bacterial 
viability kit (L-7012) was purchased from Invitrogen. A commercial strain of S. 
aureus (ATCC No. 6538) was bought from ATCC (U.S.A). Two clinical 
MRSA isolates belonging to ST239-III and ST22-IV were obtained from a 
local hospital.26  
2.2.2 Polymer synthesis 
The polymers used in this study were synthesized by Dr. Chuan Yang 
from Institute of Bioengineering and Nanotechnology. The detailed synthetic 
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procedures of MTC monomers (MTC-OPrBr and MTC-OEt) used in this 
study can be found in a previous report.27 The polymers with various 
compositions were synthesized through metal-free organocatalytic 
ring-opening polymerization of MTC-OPrBr and MTC-OEt monomers using 
HS-PEG-OH as the macroinitiator in the presence of TU and DBU catalysts 
(Scheme 2.1). The resultant polymers were quaternized with trimethylamine to 
obtain HS-PEG-cationic polycarbonate diblock copolymers (HS-PEG-CPC). 
These polymers were characterized by Gel permeation chromatograph (GPC) 
and 1H NMR spectroscopy  to analyse their polydispersity and chemical 
structures. The details of the procedure for preparation and characterization of 
the polymers were described in Appendix A. 
2.2.3 Preparation of silicone rubber 
Silicone rubbers were prepared by mixing and curing of the 
two-component kit Sylaard-184 at high temperature. Briefly, base and curing 
agents in the kit were mixed thoroughly in 10:1 (w/w), followed by vacuum 
degas for half an hour. The mixture was cast in a Petri dish (for live/dead and 
SEM studies), a 48-well plate (for colony assay) or a 96-well plate (for XTT 
assay), and kept overnight at 70°C for curing. After curing, the rubber formed 
in Petri dish was cut into pieces of 0.5 cm × 0.5 cm at a thickness of about 1 
mm. Before usage, the silicone rubber surfaces were washed by ethanol and 
de-ionized (DI) water, followed by drying with nitrogen flow.  
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2.2.4 Polymer coating on silicone rubber surface 
The cleaned silicone rubber surfaces were immersed in 2 mg/mL 
dopamine solution in 10 mM Tris buffer (pH 8.5) for 24 h.11 Before further 
treatment, the PDA-coated surfaces were rinsed with Tris buffer three times. 
HS-PEG-CPC with three compositions (polymer 1, 2 and 3) and HS-PEG at 
different concentrations were dissolved in 10 mM Tris buffer (pH 8.5). The 
PDA-coated silicone rubbers were immersed in the polymer solutions for 24 h 
at 50°C and then rinsed with Tris buffer before further characterization.      
2.2.5 X-ray photoelectron spectroscopy (XPS) measurements 
X-ray photoelectron spectroscopy (XPS, Kratos Axis HSi, Kratos 
Analytical, Shimadzu, Japan) with Al Kα source (hν = 1486.71eV) was used 
to analyse the surface chemistry of uncoated and coated rubber surfaces. The 
angle between the sample surface and detector was kept at 90°. The survey 
spectrum ranging from 1100-0 eV was acquired with pass energy of 80 eV.  
2.2.6 Static contact angle measurements 
The static contact angles on uncoated or polymer-coated surfaces were 
measured by an OCA30 contact angle measuring device (Future Digital 
Scientific Corp., U.S.A.). DI water was used for the measurements. All 
samples were analysed in triplicate. The static contact angle data are presented 
as mean ± SD.   
                                                                    
53 
 
2.2.7 Quartz crystal microbalance with dissipation (QCM-D) 
measurements  
Thickness of the hydrated polymer layer on PDA-coated surfaces was 
determined by a QCM-D device (Q-sense E4, Sweden). Gold-coated AT-cut 
quartz crystals with oscillating frequency of 4.95 MHz were used as sensors 
for the experiments. To clean the sensor surface, sensors were treated in an 
UV/Ozone chamber for 10 min, immersed in piranha solution (DI water, 
ammonia and hydrogen peroxide in a volume ratio of 5:1:1) at 75°C for 5 min, 
rinsed with DI water, and dried with nitrogen gas. The clean sensors were 
immersed in dopamine solution (2 mg/mL in 10 mM Tris, pH 8.5) for 24 h. 
The dopamine-coated sensors were washed with Tris buffer three times and 
placed in the QCM-D chamber. Change in frequency (f) and dissipation (D) 
was monitored during the flow of Tris buffer. After stable f and D baselines 
were obtained, polymer 2 in 10 mM Tris buffer (three different concentrations 
were tested) was flown over the PDA-coated sensors at a flow rate of 10 
µL/min at 50 °C for 80 min. After polymer exposure, 10 mM Tris buffer was 
pumped into the chamber to remove all loosely adhered polymers. The 
recorded f and D at four overtones (3, 5, 7 and 9) were analysed using the 
software Q-tools. The polymer layer thickness was estimated using the Voigt 
viscoelastic model. For measurement of BSA adsorption on polymer 2-coated 
surface, BSA in PBS (50 µg/mL) was pumped into the chamber at a flow rate 
of 10 µL/min. When the frequency stabilized, PBS was pumped into the 
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chamber to wash off loosely adsorbed BSA molecules. The frequency of the 
third overtone (f3) and dissipation (D3) was recorded and used to analyse BSA 
adsorption.           
2.2.8 Colony assay 
The concentration of S. aureus in tryptic soy broth (TSB) was adjusted to 
give an initial optical density (O.D.) reading of 0.07 at the wavelength of 600 
nm on a microplate reader (TECAN, Switzerland), which corresponds to the 
concentration of Mc Farland 1 solution (3  108 CFU/mL). The bacterial 
suspension was diluted by 100 times to achieve an initial loading of 3  106 
CFU/mL. 20 μL of the bacterial suspension was added to each well of a 
48-well plate, in which an uncoated or polymer-coated silicone rubber was 
placed. The 48-well plate was incubated at 37ºC for 8 or 24 h. After that, 10 
μL of the bacterial suspension was taken out from each well and diluted with 
an appropriate dilution factor. The diluted bacterial suspension was streaked 
onto an agar plate (LB Agar from 1st Base). The number of the 
colony-forming units (CFUs) was counted after incubation for about 16 h at 
37°C. Each test was carried out in triplicate. Similarly, MRSA was cultured 
overnight in cation-adjusted Mueller-Hinton broth, and the MRSA solution 
with a concentration of (6×106 CFU/mL) was used for colony assay.  
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2.2.9 Antifouling activity analysis by XTT reduction assay 
A semi-quantitative measurement of live S. aureus on the surface was 
performed by analysing 2,3-bis (2-methoxy-4-nitro-5-sulfo-phenyl)-2H- 
tetrazolium-5-carboxanilide (XTT) reduction.28 XTT assay is a method to 
measure the mitochondrial enzyme activity in live cells. During the assay, the 
optical density (OD) of orange coloured formazan dye produced from XTT 
conversion by mitochondrial enzymes in viable cells was recorded. Briefly, S. 
aureus (20 μL, 3×106 CFU/mL) or MRSA (20 μL, 6×106 CFU/mL) were 
seeded onto uncoated and coated silicone rubber surfaces and cultured for 8 or 
24 h. The rubbers were washed twice with sterile PBS and then incubated with 
100 µL of PBS, 10 µL of XTT (1mg/mL) and 2 µL of menadione (0.4 mM) in 
each well at 37°C for 2 h. The mitochondrial dehydrogenase of the bacterial 
cells reduced XTT tetrazolium salt to formazan, and the colorimetric change 
correlated with the cell metabolic activity. The absorbance at a test wavelength 
of 490 nm and a reference wavelength of 660 nm of the samples was measured 
using a microplate reader (TECAN, Sweden).  
2.2.10 LIVE/DEAD Baclight bacterial viability assay  
A LIVE/DEAD Baclight bacterial viability kit (L-7012, Invitrogen) was 
used to assess the bacterial cell viability on the surfaces. In this assay, the 
red-fluorescent nucleic acid staining agent propidium iodide, which only 
penetrates damaged cell membrane, was used to label dead bacterial cells on 
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the silicone rubber surface. In contrast, the SYTO® 9 green-fluorescent nucleic 
acid staining agent, which can penetrate cells both with intact and damaged 
membranes, was used to label all the bacterial cells. The bacteria (106 cells/mL, 
100 µL) were seeded onto the uncoated and polymer-coated silicone rubber 
surfaces, followed by incubation at 37°C for 4 h or 24 h. The supernatant was 
removed, and the silicone rubber was washed with PBS buffer three times. 
They were then incubated in a 48-well plate with 200 µL of a dyes-containing 
solution, which was prepared by adding 3 µL of SYTO (3.34 mM) and 3 µL 
of propidium iodide (20 mM) to 2 mL of PBS buffer, at room temperature in 
the dark for 15 min. The stained bacterial cells were examined under a Zeiss 
LSM 5 DUO laser scanning confocal microscope (Germany). Images were 
obtained using an oil immersed 40× object lens under the same conditions.   
2.2.11 Evaluation of biofilm formation by scanning electron microscopy 
(SEM) 
To study the biofilm formation and attachment of S. aureus on uncoated 
and polymer-coated silicone rubber surfaces, the surfaces were incubated with 
S. aureus for 7 days and then examined using SEM. Briefly, PDA, HS-PEG, 
polymer 1, 2 and 3-coated silicone rubber and uncoated silicone rubber 
surfaces were prepared by following the same procedures described in 
Sections 2.2.3 and 2..2.4. Bacteria (106 cells/mL, 100 µL) were seeded onto 
uncoated and polymer-coated silicone rubbers and incubated at 37°C for 7 
days. The culture medium TSB was changed every 24 hours. After the 
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incubation, the samples were washed with sterile PBS three times, followed by 
fixation with 2.5% glutaraldehyde in PBS for 2 h. The fixed bacteria were 
dehydrated with a series of graded ethanol solution (25%, 50%, 75%, 95%, 
and 100%, 10 min each) before platinum coating. A field emission scanning 
electron microscope (FE-SEM, JEOL JSM-7400F, Japan) was used for SEM 
analysis. 
2.2.12 Analysis of platelet adhesion 
Fresh rat blood was centrifuged at 1000 rpm/min for 10 min to obtain 
platelet-rich plasma (PRP). Uncoated and polymer 2-coated silicone rubber 
surfaces were immersed in PRP and incubated at 37°C for 0.5 h. After the 
incubation, the samples were washed with PBS three times, followed by the 
same fixation procedure and SEM observation described in section 2.2.11. 
2.2.13 Static hemolysis assay 
Fresh rat blood was obtained and diluted to 4% (by volume) with PBS 
buffer. The red blood cell suspension in PBS (100 µL) was placed on the 
pristine and polymer-coated silicone rubber surfaces in each well of a 96-well 
plate, and 100 µL of PBS was then added to each well. The plate was 
incubated for one hour at 37˚C to allow hemolysis to take place. After 
incubation, the 96-well plate was centrifuged at 2200 rpm for 5 min. Aliquots 
(100 µL) of the supernatant from each well of the plate were transferred to a 
new 96-well plate, and hemoglobin release was measured at 576 nm using the 
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microplate reader (TECAN, Sweden). In this assay, the red blood cells in PBS 
were used as a negative control and red blood cells lysed with 0.2% Triton-X 
were used as a positive control. Absorbance of wells with red cells lysed with 
0.2% Triton X was taken as 100% hemolysis. Percentage of hemolysis was 
calculated using the following formula: Hemolysis (%) = [(OD576nm of the 
sample - OD576nm of the negative control)/ (OD576nm of the positive 
control - OD576nm of the negative control) × 100. The data were expressed as 
mean and standard deviation of three replicates.  
2.3 Results and discussion 
2.3.1 Polymer synthesis and characterization 
Polymer precursors with various compositions were synthesized by 
organocatalytic ring-opening polymerization (ROP) of two functional cyclic 
carbonates MTC-OEt and MTC-PrBr using HS-PEG-OH as the macroinitiator, 
as shown in Scheme 2.1A. After quaternization of resultant precursors, 
PEG-b-cationic polycarbonate diblock copolymers 1, 2 and 3 with a thiol 
functional group on the distal end of PEG were obtained. The detailed results 
and discussion on the synthesis and characterizations are shown in Appendix 
A 




Scheme 2.1 Synthesis of aminated polycarbonates (A) and polymer coating 
process (B). 
 
2.3.2 Characterization of polymer coatings 
2.3.2.1 Surface wettability 
To examine the surface wettability change of the silicone rubber after 
treatments with PDA and HS-PEG-CPC shown in Scheme 2.1B, the static 
water contact angle of the surfaces were measured. As listed in Table 2.1, the 
static contact angle of uncoated surface was 106.3°±3.2°, suggesting the 
pristine silicone surface was hydrophobic before treatment. After applying the 
PDA coating, the surface became hydrophilic with a significantly reduced 
contact angle (53.3°±0.2°). This wettability change is in agreement with 
findings previously reported.11 Thiol-terminated PEG-b-cationic 
polycarbonates (i.e. HS-PEG-CPC) were attached onto the PDA-coated 
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surface to obtain an antibacterial and antifouling coating layer. The static 
contact angles of the surfaces coated with polymers 1, 2 and 3 increased 
slightly to 68.9°±2.0°, 68.3°±1.0° and 71°±2.6° respectively, indicating that 
the surfaces were still hydrophilic after polymer coating. The increase in the 
surface hydrophobicity after polymer coating might be due to the introduction 
of hydrophobic polycarbonate backbone. In addition, it was observed that the 
content of the hydrophobic monomer MTC-OEt did not affect the contact 
angle significantly.  
Table 2.1 Static contact angles of uncoated, PDA-, polymer 1-, 2- and 
3-coated silicone rubbers.  
 
2.3.2.2 Surface chemical composition  
To further verify successful coating of the polymers, the XPS spectra of 
silicone rubber before and after polymer coating were analysed. As shown in 
Figure 2.1A1, C1s, O1s, Si2s and Si2p peaks were present. Upon PDA coating, 
a new peak at binding energy of 396.7 eV, which corresponds to N1s, 
appeared, and thus proves that PDA was successfully coated on the silicone 
rubber surface. After dopamine treatment, the carbon atomic content increased 
from 48.7% to 59.1% and the silicon atomic content decreased from 22.8% to 
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13.4% because dopamine has a higher carbon content compared to silicone 
rubber (Table 2.2). These findings indicate successful coating of dopamine. In 
addition, three polymer-coated surfaces showed similar spectra, which consist 
of C1s, O1s, Si2s, Si2p and N1s peaks (Figure 2.1A1). The nitrogen content of 
HS-PEG-CPC decreased slightly as compared to that of PDA coating (Table 
2.2). This difference was due to the lower nitrogen content in the polymers.  
 
Figure 2.1 XPS characterization of polymer coatings. XPS wide-scan spectra 
of uncoated and polymer-coated silicone rubber surfaces (A1); 
High-resolution N1s spectra of PDA-coated (A2) and polymer 2-coated 
silicone rubber surfaces (A3). 
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In the high-resolution N1s spectra of PDA-coated (Figure 2.1A2) and 
polymer 2-coated (Figure 2.1A3) silicone rubber, the peak at 396.7 eV, which 
relates to the N-H bond, was found. In addition, in the spectrum of polymer 2 
coating, another peak at 399.1 eV was observed, which corresponds to 
nitrogen ion (i.e. N+) in the polymer, further proving the successful polymer 
coating.  
2.3.2.3 Polymer coating thickness 
The change in the hydrated polymer coating thickness was monitored by 
QCM-D in real time as a function of polymer concentration. As shown in 
Figure 2.2A, the frequency (f) decreased and the dissipation (D) increased 
when polymer solutions at different concentrations were injected into the 
QCM-D chambers, suggesting that polymer was grafted onto the PDA surface 
coating, resulting in the increase in mass and softness. In addition, larger f and 
D shifts were seen as the polymer concentration increased. This difference was 
due to the larger quantity of polymer immobilized on the surfaces at higher 
concentrations. After about 20 minutes, stable f and D were obtained, showing 
the saturation of the surfaces. To wash off loosely bound polymer molecules 
from the surfaces, Tris buffer was injected into the chambers. As expected, f 
increased and D decreased, suggesting mass and softness decreased. When the 
final equilibrium was obtained, the difference in f and D shift between 
different polymer concentrations was observed. The total changes of f value at 
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polymer concentrations of 0.075, 0.75 and 1.88 mM were about 24, 30 and 30 
Hz respectively, and the total changes of D value were around 2.8, 4 and 4 
respectively. These values suggest that grafting at higher polymer 
concentrations (0.75 and 1.88 mM) resulted in more polymer immobilized on 
the surface. Furthermore, the insignificant differences in f and D between 0.75 
and 1.88 mM indicated that the immobilized polymer was probably saturated 
on the surface. The polymer coating thickness at different concentrations at the 
equilibrium state was calculated using the viscoelastic model. As shown in 
Figure 2.2B, the hydrated polymer coating thickness increased from 5.2 to 7.0 
nm when the polymer concentration was raised from 0.075 to 0.75 mM. After 
further increasing polymer concentration to 1.88 mM, no significant difference 
in thickness was observed.    
Figure 2.2 Polymer coating characterized by quartz crystal microbalance. (A) 
Frequency shift (∆f) and dissipation shift (∆D) of the 3rd overtone as a 
function of time after polymer 2 coating at various concentrations; (B) 
Hydrated thickness of the polymer coating as a function of polymer 
concentration. 
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2.3.3 Antibacterial activity of polymer coatings against S. aureus 
The colonies of S. aureus in the solution after 8 h or 24 h of incubation 
with untreated and treated silicone rubber were counted to determine the 
antibacterial activity of polymer coatings. As shown in Figure 2.3A, the 
number of colonies in the solution incubated with the untreated silicone rubber 
at 8 h and 24 h was 5.4 × 109 CFU/mL and 3.3 × 1012 CFU/mL respectively, 
which had no significant difference when compared to that of the solution 
incubated with PDA-coated silicone rubber (3.4 × 109 CFU/mL and 3.9 × 1012 
CFU/mL respectively). For the silicone rubber coated with HS-PEG without 
cationic polycarbonate at various polymer concentrations, the number of 
bacterial colonies in solution was around 6 × 109 CFU/mL and  3 × 1012 
CFU/mL respectively, suggesting that PEG coating did not kill the bacteria in 
the solution. The silicone rubbers coated with polymer 1 and 2 with the 
hydrophobic monomer MTC-OEt at the concentrations of 0.75 and 1.88 mM 
exhibited antibacterial activity in the solution. In particular, when the surface 
was coated with polymer 1 or 2 at 1.88 mM, no colony was found at both 8 h 
and 24 h. However, the coating with polymer 3 without the hydrophobic 
monomer showed no antibacterial activity in solution even at the highest 
concentration. These results indicated that the hydrophobic component in the 
polymer coating is important to render the surface antibacterial. This 
observation is in agreement with previous findings,23 where cationic 
polycarbonates without a hydrophobic component did not kill bacteria.  




Figure 2.3 Antibacterial (A) and antifouling (B) activities of polymer coatings 
against S. aureus. The bacteria colonies in solution (A) and bacterial metabolic 
activity (B) on the uncoated surface and surfaces coated with various polymers 
at different concentrations after 8 and 24 h of incubation. 1, 2, and 3 
correspond to polymer concentrations of 0.075, 0.75 and 1.88 mM 
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2.3.4 Antifouling activity of polymer coatings against S. aureus 
To examine the bacterial adhesion and growth on uncoated and 
polymer-coated silicone rubber surfaces, a XTT assay was performed. The 
XTT assay is a widely used method to determine bacterial cell viability. In this 
assay, a higher OD reading correlates to more live cells adhered on the surface. 
As shown in Figure 2.3B, the OD reading of uncoated silicone rubber was 
about 0.17 after 8 h of incubation, which increased to 0.35 at 24 h. This 
suggests that a relatively small number of viable bacterial cells attached on the 
surface after 8 h, and the cell number significantly increased at 24 h. These 
results indicate that silicone rubber surfaces are prone to S. aureus adhesion 
and growth. The higher OD value with PDA-coated rubber at 8 and 24 h 
indicated higher affinity of S. aureus to the PDA coating. The PDA-enhanced 
cell attachment was also observed for mammalian cell.29 For the polymer 
coatings, the surfaces coated with HS-PEG and polymer 3 without a 
hydrophobic component at 1.88 mM showed medium antifouling activity with 
the OD values of 0.03 and 0.04 respectively after 24 h of incubation. However, 
polymer 1 and 2 coatings demonstrated greater antifouling activity with OD 
values of less than 0.01, suggesting that the incorporation of hydrophobic 
monomer in the polymers enhanced antifouling activity. The antifouling 
activity of all polymer coatings most likely comes from PEG. PEG or 
PEG-based polymers have been reported in the literature as a classic coating to 
prevent microbial fouling.12, 30-33 This nonfouling property is due to the 
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flexible chain and large steric repulsive forces of PEG molecules that prevent 
microbial cells from approaching the substrate.34 The improved antifouling 
efficiency provided by polymer 1 and 2 coatings is probably due to the 
antibacterial activity of polymers with hydrophobic components, which might 
synergistically prevent bacterial cell fouling.    
To further confirm the antifouling property of polymer-coated silicone 
rubber surfaces, LIVE/DEAD backlight bacterial viability assay was 
performed. From Figure 2.4, a large number of live bacterial cells (green dots) 
can be found on the uncoated and PDA-coated surfaces, especially after 24 h 
of incubation. However, there were no live bacterial cells found on polymer 
2-coated rubber surface after 24 h of incubation, indicating excellent 
antifouling activity of the polymer coating. Although there were a 
significantly lower number of live bacterial cells found on the PEG-coated 
surface at 4 h as compared to the uncoated and PDA-coated surfaces, there 
were still live bacterial cells found at 24 h. These results suggest better 
antifouling activity of the polymer 2 coating than the PEG coating, which is in 
agreement with the XTT assay findings.      
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Figure 2.4 Live/dead cell staining on the uncoated surface and the surfaces 
coated with PDA, PEG and polymer 2 after 4 and 24 h of incubation with S. 
aureus. Size of the scale bars: 10 µm. 
 
2.3.5 Antibacterial and antifouling activities against MRSA 
Similar to the results of S. aureus, PDA and PEG coatings did not show 
antibacterial activity against MRSA as compared to uncoated silicone rubber 
surface with over 5.0 × 109 CFU/mL detected (Figure 2.5A). However, the 
surfaces coated with polymer 1 and 2 at the concentrations of 0.75 mM and 
1.88 mM demonstrated antibacterial activity against MRSA. More importantly, 
the surfaces coated with polymer 1 and 2 at the concentration of 1.88 mM 
killed all the MRSA in the solution. In contrast, the surface coated with 
polymer 3 did not show apparent antibacterial activity. As shown in Figure 
2.5B, the OD value of uncoated silicone rubber was about 0.30 after 8 h of 
incubation, indicating silicone rubber surface was more prone to MRSA 
adhesion and growth than S. aureus. Compared to the uncoated surface, the 
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PDA-coated surface exhibited a lower OD reading of 0.1, which suggests that 
less MRSA was attached. However, the surfaces coated with HS-PEG at 
various concentrations showed more apparent antifouling activity with OD 
value of around 0.03. Moreover, polymer 1 and 2 coatings prepared at the 
concentration of 0.75 mM demonstrated similar antifouling activity to that 
observed for the PEG coating, and surface coated with polymer 2 at the 
concentration of 1.88 mM demonstrated even greater antifouling activity than 
PEG coating with OD value of 0.018. Among all the polymers, polymer 3 
coating showed the least antifouling activity even at the highest concentration. 
These findings proved that the surfaces coated with polymer 1 and 2, 
which have hydrophobic monomer MTC-OEt, at high concentrations not only 
killed planktonic MRSA in solution, but also inhibited MRSA fouling on the 
surfaces.   
 




Figure 2.5 Antibacterial (A) and antifouling (B) activities of polymer coatings 
against MRSA. The colonies of the bacteria in solution (A) and bacterial 
metabolic activity (B) on the uncoated surface and surfaces coated with 
various polymers at different concentrations specified after 8 h of incubation. 
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2.3.6 Prevention of biofilm formation 
 
Figure 2.6 SEM images of the uncoated surface and the surfaces coated with 
PDA, PEG and polymer 2 after 7 days of incubation with S. aureus. 
 
Biofilm formed on surfaces consisted of bacteria, their secretion and host 
polymers.35 Mature biofilm is observed within 7 days of exposure to S. 
aureus.36 Therefore, in this study, S. aureus biofilm was developed on the 
uncoated and coated silicone rubber surfaces by incubation of these surfaces 
with bacterial suspension for 7 days. As shown in Figure 2.6, a great number 
of bacterial cells were found on the uncoated, PDA- and PEG-coated surfaces 
at 7 days. In sharp contrast, no bacterial cells and no trace of biofilm were 
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found on the polymer 2-coated silicone rubber surface although ruptured cell 
fragments were seen, suggesting that the antifouling and antibacterial activity 
of the polymer 2 coating can be preserved for an extended period of time. 
 
2.3.7 Static blood compatibility 
Blood compatibility of the coatings was evaluated via BSA adsorption, 
platelet adhesion and hemolysis analysis. When surfaces are in contact with 
blood, blood proteins can be adsorbed quickly, followed by platelet adhesion 
and activation, which will result in thrombus formation.37, 38 Albumin, the 
most abundant protein in bloodstream, was used to study blood protein 
adsorption on the polymer coated surfaces. From the real-time frequency shift 
(∆f) and dissipation shift (∆D) of QCM-D in Figure 2.7, large ∆f and ∆D were 
found on the PDA-coated surface, which indicates that BSA was easily 
adsorbed on PDA-coated surface. Moreover, the frequency and dissipation 
values were stable after washing with PBS, suggesting that the BSA 
adsorption was stable on the PDA-coated surface. The strong interaction 
between BSA and PDA-coated surface is due to the reactive PDA coating 
which can react with amine groups of BSA. In contrast, for polymer 2-coated 
surface, the small changes in ∆f and ∆D indicate that the mass and softness 
hardly changed when BSA was pumped over the surface, suggesting that there 
was no significant BSA adsorption on this surface. The prevention of protein 
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adsorption is most likely due to the incorporation of PEG molecules in the 
polymer coating. 
 
Figure 2.7 Real-time frequency shift (∆f) and dissipation shift (∆D) of the 
QCM-D as a function of time in the presence of BSA. 
 
Blood platelet adhesion on the uncoated and polymer 2-coated silicone 
rubber surfaces was examined by SEM. As shown in Figure 2.8, a large 
number of adhered platelets were found on the uncoated silicone rubber 
surface. However, on polymer 2-coated surface, no adhered platelets were 
observed. These results proved that the polymer 2 coating was able to 
eliminate platelet adhesion, preventing further thrombus formation.       
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Figure 2.8 SEM images of platelet adhered on the uncoated silicone rubber 
surface (A) and the surface coated with polymer 2 (B). The insertion in image 
(A) is magnified platelet image on the uncoated silicone rubber surface. Size 
of the scale bars: 10 µm. 
Figure 2.9 shows the degree of hemolysis after red blood cell contact with 
the uncoated, PDA- and polymer 2-coated silicone rubber surfaces. Similar to 
the uncoated silicone rubber, the surfaces coated with PDA and polymer 2 at 
various concentrations did not cause significant hemolysis, which is desirable 
for future clinical applications. 
















Figure 2.9 Hemolysis evaluation of the uncoated surface and surfaces coated 
with PDA and polymer 2 at various concentrations. 




A series of diblock copolymers of PEG and cationic polycarbonates 
(PEG-b-cationic polycarbonates), which were synthesized by metal-free 
organocatalytic ring-opening polymerization, have been successfully grafted 
onto silicone rubber surfaces through an reactive polydopamine coating layer. 
The polymer coatings with a hydrophobic component eradicated S. aureus and 
MRSA in solution, and efficiently prevented their fouling on surfaces. In 
particular, the polymer 2-coated surfaces with the optimal polymer 
composition exhibited significantly higher antifouling activity than the 
PEG-coated surfaces. Furthermore, the polymer coating inhibited biofilm 
formation without causing significant hemolysis, blood protein adsorption or 
platelet adhesion. Therefore, these PEG-b-cationic polycarbonates hold great 
potential as antibacterial and antifouling coatings for the prevention of 
intravascular catheter-associated infections. 
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Chapter 3. Antimicrobial and Antifouling Hydrogels Formed In Situ 
from Polycarbonate and Poly (ethylene glycol) via Michael Addition 
3.1 Background 
In the previous Chapter, the diblock copolymers with quaternary 
ammonium and PEG were grafted onto surfaces of catheter materials to 
provide an antibacterial and antifouling coating via a two-step process with the 
assistance of an intermediate polydopamine (PDA) layer. This coating is 
effective in killing S. aureus including methicillin-resistant S. aureus (MRSA), 
and preventing the fouling of these bacterial cells. However, grafting 
efficiency of diblock copolymers on PDA pre-treated surfaces was relatively 
low and most copolymers were removed during the washing process. 9This 
was due to the fact that only one thiol functional group is available in each 
polymer chain, and this thiol group acts as an anchor group to bind the 
polymer onto a thin layer of PDA. In addition, the aforementioned coating is 
ineffective to prevent the fouling of Gram-negative bacteria (e.g. E. coli). To 
overcome these problems, a PEG hydrogel with chemical incorporation of 
antimicrobial cationic polycarbonates (CPCs) was designed and coated onto 
silicone surfaces. This PEG-based hydrogel was expected to exhibit better 
antifouling activities due to the nonfouling hydrogel matrix.    
Hydrogels with antimicrobial activities have recently emerged as a 
promising platform to treat MDAIs and wound healing.1-3 For example, PEG 
hydrogels incorporating cationic chitosan that was grafted with PEG exhibited 
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excellent antimicrobial activity against various bacteria and fungi.3-5 In 
addition, a zwitterionic carboxybetaine ester hydrogel has been employed by 
Jiang and co-workers to load the antibacterial agent salicylate as an 
counterion.6 This antibacterial agent was delivered in a controlled manner 
from the gel, and the zwitterionic polymers left behind after hydrolysis then 
acted as an antifouling coating to prevent the adhesion of bacteria. However, 
hydrogels with both antibacterial and antifouling properties are scarce, and the 
coating characteristics present in this type of hydrogels on catheter surfaces 
have yet to be fully explored.  
Therefore, this study aimed to design an antimicrobial hydrogel with 
antifouling activity, and coat the hydrogels onto catheter surface in a facile 
manner to prevent CAIs. Firstly, an antimicrobial diblock copolymer of PEG 
and cationic polycarbonate described in Chapter 2, was chemically 
incorporated into PEG hydrogels that were fabricated via Michael addition 
chemistry. The broad-spectrum antimicrobial activity against various 
pathogenic microbes and clinically isolated multidrug-resistant bacteria were 
then studied. In addition, the toxicity of hydrogels towards mammalian cells 
and skin toxicity in animal models was examined. Finally, these hydrogels 
were coated onto the silicone rubber, and their antimicrobial and antifouling 
activities were studied.  
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3.2 Materials and methods 
3.2.1 Materials 
Similar materials were used as described in Chapter 2. Tetra acrylate PEG 
(Mw 10,000) and tetra sulfhydryl terminated PEG (Mw 10,000) were obtained 
from Sunbio (South Korean). Fungi C. albicans (ATCC No. 10231) were 
purchased from ATCC (U.S.A) and re-cultured according to the suggested 
protocols. Clinically isolated Gram-positive bacteria methicillin-resistant S. 
aureus (MRSA) and vancomycin-resistant enterococcus (VRE), 
Gram-negative bacteria A. baumannii and fungi C. neoformans, were extracted 
from patients’ phlegm and kindly provided by Dr. K. J. Xu, Department of 
Infectious Diseases, the First Affiliated Hospital, College of Medicine, 
Zhejiang University, P. R. China. The clinical microorganisms were grown in 
Mueller-Hinton broth at 37°C. 
3.2.2 Polymer synthesis 
The same polymers used as Chapter 2 were synthesized by Dr. Chuan 
Yang from Institute of Bioengineering and Nanotechnology. The details of 
polymer synthesis were described in Appendix A. In this study, CPC (m-n) 
denotes the polymer with m repeat units of MTC-OPrBr and n repeat units of 
MTC-OEt. Therefore, polymer 3, polymer 2 and polymer 1 used in the last 
chapter corresponds to CPC (18-0), CPC (18-10) and CPC (18-25), 
respectively. In addition, one more polymer CPC (14-7) was studied in this 
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chapter.    
PC (14-7), PDI: 1.20; Yield, 85%. 1H NMR (400 MHz, CDCl3, 22 °C): 
4.30 (m, 126H, H of –CH2OCOO- and -OCH2-), 3.62 (s, 455H, H of 
-PEG-), 3.48 (t, 28H, -CH2Br), 2.19 (m, 28H, -CH2CH2Br), 1.25 (m, 84H, 
-CH3). 
CPC (14-7), Yield, ~100%. 1H NMR (400 MHz, DMSO-d6, 22 °C): 
4.05-4.23 (m, br, 126H, H of -CH2OCOO- and -OCH2-), 3.37 (s, 483H, H of 
-CH2N- and -PEG-), 3.03 (s, 126H, -NCH3), 2.07 (s, 28H, -CH2CH2N-), 
1.12 (m, 84H, -CH3). 
3.2.3 Preparation of PEG-CPC hydrogels via Michael addition 
Hydrogel PEG-CPC (18-25)-2 as a typical example was prepared by 
dissolving tetra acrylate PEG (1.85 mg, 0.185 mol) in triethanolamine buffer 
(TEOA, 0.3 M, pH 8.0) and followed by reaction with thiol-functionalized 
CPC (CPC (18-25), 1.57 mg, 0.10 mol) (Scheme 3.1a)  The resultant 
solution was then incubated at 37˚C for 2 h. Tetra sulfhydryl PEG (1.6mg, 0.16 
mol) was added to the solution and incubated at 37˚C for several minutes to 
form the hydrogel. The final precursor concentration was 10 (w/v) %, and the 
molar ratio of thiol to vinyl group was 1:1. Ellman’s reagent was used to 
determine the concentration of remaining thiol group to monitor the reaction.7, 
8 Briefly, CPC (18-10) solution (9.6 mg, 200 μL of TEOA) was mixed with 
tetra acrylate PEG solution (16 mg, 50 μL of TEOA). Aliquots (50 μL) of the 
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resultant mixture were withdrawn in predetermined time point for Ellman’s 
analysis. The absorbance of the mixture at 412 nm was measured using a 
UV-VIS spectrometer (Shimadzu, UV-2501PC, Japan), and SH-PEG-OH (Mw 
5000) was used as standard. 
3.2.4 Hydrogel characterization 
The physical and antimicrobial properties of hydrogels were 
characterized by Dr. Shaoqiong Liu from Institute of Bioengineering and 
Nanotechnology. Details of experiments were shown in Appendix B.  
3.2.5 Surface coating on silicone rubber 
The silicone rubber was cleaned ultrasonically in 2-propanol for 10 min, 
and was then coated with dopamine using a modified method as described by 
Messersmith et al.9 Briefly, the silicone substrate was coated with a thin layer 
of PDA under basic condition as same as described in Chapter 2. The resulting 
polydopamine layer was rinsed with Tris buffer and subsequently reacted 
covalently with tetra sulfhydryl PEG. Then tetra acrylate PEG with partially 
conjugated CPC was added and a hydrogel was form in situ on the silicone 
surface (Scheme 3.1b). 
3.2.6 Confocal laser scanning microscopy (CLSM) 
50 μL of S. aureus suspension with 3.5×106 CFU/mL was added onto the 
gel-coated silicone rubber surface. Silicon rubber surfaces without coating and 
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surfaces coated with PEG gel were used as controls. The samples were 
incubated for 1 day at 37°C. The samples were stained with a 0.9% NaCl 
solution containing 2.5 μM of green fluorescence SYTO 9 (Invitrogen, U.S.A.) 
and 10 μM of red fluorescence propidium iodide (Invitrogen, U.S.A.) for 20 
min at room temperature, followed by gentle rinse with a 0.9% NaCl solution. 
Then samples were analysed by a confocal microscope (LSM 510 META, 
Germany). Overlay images were obtained with confocal software. 
3.2.7 Hemolysis assay 
Please refer to section 2.2.13 for the details of hemolysis assay.   
 
Scheme 3.1 Synthetic schemes of PEG-CPC hydrogel formation (a) and 
hydrogel coated onto silicone surface (b).  
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3.3 Results and discussion 
3.3.1 Polymer synthesis and characterization 
The same polymers CPC (18-0), CPC (18-10) and CPC (18-25) 
corresponding to polymer 3, polymer 2 and polymer 1 respectively in the 
Chapter 2 were used in this study. In addition, one more polymer CPC (14-7) 
where 14 is the number of repeat unit of cationic groups and 7 is the number 
of repeat units of hydrophobic ethyl groups was investigated. The detailed 
results and discussion on the polymer synthesis were shown in Appendix A.  
 




















CPC (18-0) 18 0 11120 10.4 224.8 112.4 
CPC (14-7) 14 7 12000 5.6 208.3 41.7 
CPC (18-10) 18 10 13080 4.8 95.6 38.2 
CPC (18-25) 18 25 15782 2.0 31.7 23.1 
a Mn is the number average molecular weight. 
 
The characterization of CPCs was shown in Table 3.1. The minimum 
inhibition concentrations (MICs) were tested to evaluate the antimicrobial 
activities of CPCs in solution. The low MICs value against S. aureus shown in 
Table 3.1 implies effectiveness of all the polymers against Gram-positive 
bacteria. However, polymers without or with a few hydrophobic monomers 
displayed decreased antibacterial activities against Gram-negative bacteria E. 
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coli and fungus C. albicans than the polymer with more hydrophobic 
monomers (i.e. CPC(18-25)). This is probably due to the increase of polymer 
hydrophobicity resulting in enhanced the interactions between microbial 
membranes and the polymer.   
3.3.2 Hydrogel characterization 
The characterization of hydrogels was carried out by Dr. Shaoqiong Liu 
from Institute of Bioengineering and Nanotechnology. A two-step protocol 
was applied to incorporate cationic PEG-CPCs into hydrogels.10 PEG, as a 
classical antifouling compound,11, 12 was chosen to build the hydrogel network 
in this study. In the first step, PEG partially conjugated with CPC was 
prepared by mixing a tetra-acrylate functional PEG and the thiol-containing 
CPC in the buffer solution. The hydrogel could be formed in minutes with the 
addition of tetra-sulfhydryl PEG. The reactivity of acrylate groups towards 
thiol-containing CPC was evaluated using Ellman’s reagent.13 The results 
indicated that thiol group was gradually consumed within 2 h at 37C (pH 
8.0).  
The physical properties of PEG-CPC hydrogels were shown in Table 3.2. 
Hydrogels without CPC were formed within 2 minute (control gel). As CPC 
concentration increased, longer gelation time and lower storage moduli (G) 
were observed. These changes are due to decreased crosslinking density 
resulting from increased CPC concentration. These results indicate that 
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hydrogel with incorporation of CPCs could be quickly formed in situ under the 
physiological conditions. In addition, by changing the precursor concentration, 
physical properties of the hydrogels can be easily tuned, which is important 
for different applications.14 
 











S. aureus E. coli C. albicans 
Control: PEG 0 2 4056.0 - - - 
1: PEG-CPC(18-0)-2 2.0 5 3520.3 ≥99.999 - 99.2290.036 
2: PEG-CPC(14-7)-2 2.0 6 3137.2 ≥99.9999 98.40.439 99.4290.075 
3: PEG-CPC(18-10)-2 2.0 8 2642.7 ≥99.9999 99.8940.001 99.8450.007 
4: PEG-CPC(18-25)-2 2.0 10 2175.0 ≥99.9999 99.9960.003 ≥99.9999 
4-3: PEG-CPC(18-25)-3 3.0 14 1175.2 ≥99.9999 99.9980.001 ≥99.9999 
b Ge: defined as G′ value at frequency of 1 Hz. 
- indicating no microbial inhibition observed. 
3.3.3 Antibacterial activities of hydrogels 
Since Gram-positive bacteria, Gram-negative bacteria and fungi are the 
main organism contributing to MDAIS,15 S. aureus, E. coli and C. albicans 
were used as model microorganisms to assess the antibacterial activities of the 
hydrogels. In this study, the hydrogels formed in tissue culture plate (TCP) 
were challenged with suspension of pathogens (3.5×108 CFU/mL). TCP and 
PEG hydrogel were used as controls. The number of microbial cells on 
hydrogel surfaces was quantified by a spread plate method, and the results of 
killing efficacy were listed in Table 3.2. The microbial growth on hydrogel 
surface was evaluated by optical density (OD) measurement and the results 
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were shown in Figure 3.1. It is noted that the initial attachment of microbes 
and proliferation was reduced on PEG hydrogels compared with TCP surfaces, 
but PEG hydrogels were not able to kill microbes (Table 3.2) and inhibit their 
growth (Figure 3.1) once they were attached to the surfaces.  
 
Figure 3.1 Growth inhibition of TCP (control), PEG gel (control) and gel 4 
against Gram-positive bacteria S. aureues (a), Gram-negative bacteria E. coli 
(b) and fungi C. albicans (c). (Higher OD reading indicating more microbes in 
growth medium). 
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The incorporation of cationic CPC in the hydrogels resulted in excellent 
antimicrobial activities. All hydrogels with cationic CPC displayed high 
killing efficiency against S. aureus (Table 3.2), and the hydrogels 
incorporating CPC with the hydrophobic component MTC-ethyl (gel 2, gel 3 
and gel 4 in Table 3.2) also exhibited antimicrobial activities against E. coli 
and C. albicans. The similar trend of the polymers in solution (Table 3.1) and 
in hydrogels (Table 3.2) was observed that higher hydrophobic content leads 
to greater antimicrobial efficacy against E. coli and C. albicans. The hydrogels 
were more effective against Gram-positive bacteria than Gram-negative 
bacteria, because there is an additional membrane as the utmost layer for 
Gram-negative bacteria and the cell wall of Gram-positive bacteria carries 
more negative charges.16, 17 And due to the additional layer of Gram-negative 
bacteria, more hydrophobic components are needed to interact with and 
disrupt the cell membrane.18 Therefore, gel 4 exhibited broad-spectrum 
antimicrobial activities, and could inhibit the microbial growth with more than 
99.99% killing efficiency for all the tested microbes (Figure 3.1, Table 3.2). 
Moreover, killing efficiency against E. coli could be further improved by 
increasing the CPC concentration from 2 (gel 4) to 3 mM (gel 4-3). 
The antimicrobial activities of gel 4 were further proven by testing 
clinically isolated methicillin-resistant S. aureus (MRSA, Gram-positive) and 
vancomycin-resistant enterococcus, multidrug-resistant A. baumannii 
(Gram-negative) and C. neoformans (fungi) which are pervasive in hospitals.15 
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Similar to the results obtained in Figure 3.1 and Table 3.1, the growth of all 
microbes was inhibited, and extremely high killing efficiency was observed 
(99.9% for C. neoformans and more than ≥99.9999% for MRSA, VRE and A. 
baumannii) after contacting with gel 4 for 8 h.  
The stability of hydrogels was evaluated by challenging them with S. 
aureus (3.5×106 CFU/mL) every day. It was found that high antimicrobial 
activities (≥99.9999% killing efficiency) of gel 4 could be maintained for three 
days. Then the antimicrobial activity slightly decreased with more than 99.0% 
killing efficiency. However, gel 4-3 with 3 mM CPC (18-25) exhibited more 
than 99.9% killing efficiency even at Day 12. These results suggested the 
prolonged antimicrobial activity of the cationic PEG-CPC hydrogels. 
3.3.4 Antibacterial and antifouling activities of coatings with hydrogels 
To prove the feasibility of coating cationic PEG-CPC hydrogels on 
surfaces, gel 4 was in situ immobilized onto the surface of silicone rubber, a 
commonly used catheter material (Scheme 3.1b). The silicone substrate was 
first immersed in a dopamine solution (2 mg/mL, 10 mM Tris-HCl, pH 8.5) 
for 24 h to form a reactive PDA layer.9 Thiol-containing tetra-sulfhydryl PEG 
was subsequently coated with PDA through Michael addition reaction.9 A 
hydrogel coating layer was formed by adding tetra-acrylate PEG conjugated 
with CPC. After incubation with S. aureus for 24 h, numerous viable S. aureus 
cells were found on both pristine silicone surface and the PEG gel-coated 
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surface (Figure 3.2a1 and a2), although a reduction in the number of cells on 
the PEG-coated surface was observed due to its non-fouling property. In sharp 
contrast, no live bacterial cells were detected on gel 4-coated silicone surface 
(Figure 3.2a3), because gel-coated rubber surface was able to completely kill S. 
aureus upon contact (Figure 3.2b) and subsequently removed them by rinsing 
with buffer solution. The same results were also observed for E. coli cells. 
These observations demonstrated that the cationic PEG-CPC hydrogels were 
able to be coated on silicone surfaces via a reactive PDA layer and this 
hydrogel coating possesses superior antimicrobial and antifouling activities.  
 
Figure 3.2 Antibacterial activities of silicone surfaces with and without 
hydrogel coating. (a) Confocal images of surfaces incubated with S. aureus for 
24 h: (a1) Pristine silicone surface, (a2) silicone surface coated with PEG 
hydrogel, (a3) silicone surface coated with gel 4. Inserts are 3D overlay 
images. (b) Number of bacterial cells (S. aureus and E. coli) in bacterial 
suspension on gel 4-coated silicone surfaces and pristine silicone surface after 
incubation with bacteria for 24h. Solid circle indicating no CFUs found.   
To investigate the antimicrobial mechanism of the cationic hydrogels, 
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morphological changes of S. aureus and E. coli before and after the contact 
with the hydrogels were examined by SEM. As shown in Figure 3.3a and d, S. 
aureus and E. coli without treatment exhibited intact cell wall. After treatment 
with PEG hydrogel, the same morphologies of bacterial cell wall were 
observed indicating nontoxicity of PEG hydrogel for bacterial cells. However, 
aggregations of lipid vesicles-like structure were found for the bacteria 
contacting with gel 4 for 2 h. (Figure 3.3c and f). It is hypothesized that the 
anionic bacterial cell membrane was first attracted to the surface of cationic 
hydrogel via electrostatic interaction, then the hydrophobic segments of 
hydrogel inserted into the hydrophobic lipid membrane and induced 
membrane leakage resulting in the formation of vesicle-like structures and cell 
lysis.  
 
Figure 3.3 SEM images of S. aureus (a-c) and E. coli (d-f) after being contact 
with PEG hydrogel (b, e) and gel 4 (c, f) for 2 hours. TCP (a, d) was used as 
controls.   
An agar plate assay was employed to examine if the antimicrobial 
activities were due to the releasing of antimicrobial polymer or contact killing. 
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The gel 4 precursors were casted and gel 4 formed in situ on agar plates that 
had been inoculated with S. aureus, and then the plates with gel and bacteria 
were incubated at 37C for 24 h. As shown in Figure 3.4, no bacterial colonies 
were found under the gel 4 throughout 2 weeks, while PEG gel exhibited no 
antimicrobial activities and allowed the growth of S. aureus on agar plate. In 
addition, bacterial colonies were still observed in the vicinity of gel 4, 
indicating no antimicrobial polymers were leaked out from the hydrogel and 
the antimicrobial activities was due to the contact killing.  
 
Figure 3.4 Agar plate assay to test contact killing activities. Agar plates with 
gel 4 (left) and PEG hydrogel (right) in the centre of the plates incubated with 
S. aureus for 2 weeks.  
3.3.5 Biocompatibility of hydrogels 
Hemolytic activity of the hydrogels was assessed by soaking them in rat 
blood for 1 h. Negligible hemolytic activity was observed for the gel surfaces 
with various formulations (Figure 3.5). Moreover, acute dermal toxicity, skin 
sensitization and skin irritation of gel 4 were performed to evaluate its safety 
for future clinical applications by using rat, guinea pig and rabbit models, 
respectively. A high value of LD50 of the hydrogel (≥2000 mg/kg) was 
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observed and the hydrogel exhibited no adverse effects, indicating its excellent 
biocompatibility. The different toxicity of hydrogel against mammalian cell 
and microbes could be due to the less negatively charge on mammalian cell 
surface, resulting in less electrostatic interaction between the surfaces of 
mammalian cells and hydrogels.19 
 
Figure 3.5 Hemolytic activity of hydrogels with various formulations. 
 
3.4 Conclusion 
In conclusion, a cationic polycarbonate (CPC) was incorporated into PEG 
hydrogel networks via Michael addition to from an antimicrobial hydrogel. The 
hydrogels displayed broad-spectrum antimicrobial activity with more than 99.9% 
killing efficiency against multidrug-resistant Gram-positive and Gram-negative 
bacteria as well as fungi. More importantly, the hydrogels with the optimal 
compositions were successfully coated onto the surface of catheter material via 
a reactive PDA intermediate layer, and this hydrogel coatings exhibited 
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excellent antibacterial activity by contact killing and good antifouling activity. 
In addition, this hydrogel showed no significant hemolytic activity or skin 
toxicity. Therefore, this antimicrobial and antifouling hydrogel is promising as 
catheter coatings for prevention of CAIs.  
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Chapter 4. Brush-Like Polycarbonates Containing Dopamine, Cations 
and PEG Providing Broad-Spectrum Antibacterial and Antifouling 
Surface via One-Step Coating 
4.1 Background 
As was covered in Chapter 1, a variety of different coating methods have 
been applied to coat catheters for prevention of CAIs. However, it is difficult 
to obtain an effective and facile coating without elevating toxicity of the 
catheter surfaces. In Chapter 2, a two-step antibacterial and antifouling coating 
was reported by using a diblock copolymer of thiol-functionalized PEG and 
cationic polycarbonate, i.e., 1) attaching a reactive polydopamine (PDA) layer 
onto the catheter surface and 2) reacting the diblock copolymer with the PDA 
layer via the thiol group on the distal end of PEG.1 This coating successfully 
eradicated S. aureus in bacterial suspension, and prevented bacterial fouling 
on the catheter surface along with excellent blood compatibility. However, this 
coating failed to kill and prevent fouling of Gram-negative bacteria (e.g., E. 
coli), which often cause CAIs. In Chapter 3, PEG hydrogels incorporated with 
antibacterial polycarbonates were coated onto silicone surfaces via a reactive 
PDA intermediate layer, and this hydrogel coating displayed excellent 
antibacterial and antifouling activities against both Gram-positive and 
Gram-negative bacteria. However, this coating took several steps to implement 
and was relatively complicated. As a common strategy in Chapter 2 and 
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Chapter 3, dopamine was used to form a PDA adhesive layer on silicone 
surfaces, and simultaneously this PDA layer acted as a reactive intermediate 
layer to graft thiol-functionalized polycarbonates. As another approach to take 
advantage of the adhesive property of dopamine/PDA, dopamine and its 
analogues have been incorporated in the polymer chain to obtain a one-step 
coating, and this has been reviewed in section 1.5. However, polymers 
containing dopamine or its analogues have yet to be used to coat on inert 
silicone surfaces for antibacterial and antifouling applications. Moreover, an 
organic solvent instead of an aqueous medium was used for the coating of 
most polymers containing dopamine or its analogues,2, 3 and the usage of 
organic solvents may be a potential risk for catheter coatings.4 Therefore, used 
polymers which contain not only antibacterial and antifouling moieties but 
also adhesive dopamine, for the first time, were adopted to coat silicone 
surfaces using aqueous solution in this study. By employing this strategy, a 
simpler coating process than those covered in Chapter 2 and Chapter 3 could 
be achieved, alongside a broad-spectrum antibacterial coating obtained by 
optimizing the composition of the polymers. 
In order to obtain a polymer coating with broad-spectrum antibacterial 
effects and to further simplify the coating process, a series of brush-like 
polycarbonates containing all three key components such as pendent dopamine 
(for adhesion of polymer to substrate) and short PEG (for antifouling property) 
as well as cations for electrostatic targeting of microbes and membrane lysis, 
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were synthesized with precise control over the molecular composition through 
the use of organocatalytic ring opening polymerization (ROP) (Scheme 4.1A). 
In particular, the antibacterial polycarbonate was designed to contain a 
wet-resistant adhesive function inspired by the amino acid sequence of mussel 
adhesive protein, Mytilus edulis foot protein-5 (Mefp-5). This bio-inspired 
adhesive moiety was conjugated to the polycarbonate via facile chemistry to 
provide catecholamines, which mimics the side chain chemistry of the 
repetitive di-peptide of 3,4-dihydroxy-L-phenylalanine (Y)-histidine (H) in the 
adhesive catecholamine (Scheme 4.1B). 5-8  
In this study, the coating condition was optimized and the effects of each 
component were systematically investigated to explore the coating mechanism. 
Next, the antibacterial and antifouling activities were examined. In addition, 
the long-term stability and hemocompatibility including hemolysis, protein 
adsorption and platelet adhesion were studied.  
 
4.2 Materials and methods 
4.2.1 Materials 
Similar materials were used as described in Chapter 2. 1-octadecanethiol 
(1-ODT) was bought from Sigma-Aldrich and used as received. 
Monomethoxy poly (ethylene glycol)s (PEG, Mn 750 Da, PDI: 1.03; Mn 5000 
Da, PDI: 1.04) was purchased from Polymer Source Inc., Canada, which was 
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azeotropically distilled from toluene and dried in vacuo prior to use. Silicone 
catheter was a gift from National University Hospital of Singapore. 
4.2.2 Polymer synthesis and characterization 
Polymers employed in this study were synthesized by Dr. Chuan Yang 
from Institute of Bioengineering and Nanotechnology. The polymers with 
various compositions were synthesized through metal-free organocatalytic 
ring-opening polymerization of MTC-BnCl and MTC-PEG monomers in the 
presence of TU and DBU as co-catalysts (Scheme 4.1A). The obtained 
polymers reacted with the primary amine group in dopamine to incorporate 
dopamine into the polymer. Finally, the resultant polymers were quaternized 
with trimethylamine, N,N-dimethylbutylamine or N,N-dimethyl benzylamine 
to obtain the polymers containing cations, PEG and dopamine. These 
polymers were characterized by Gel permeation chromatograph (GPC) and 1H 
NMR spectroscopy to analyse the polydispersity and chemical structures of 
the polymers. The details of the procedure for preparation and characterization 
of the polymers were described in Appendix C. 
4.2.3 Polymer coating on silicone rubber and silicone catheter 
A two-component kit Sylaard-184 was used to prepare silicone rubber. 
Base and curing agents in the kit were mixed thoroughly and casted on a glass 
slide (for live/dead cell staining and confocal studies), in a 96-well plate (for 
hemolysis test) or a 48-well plate (for colony assay). After curing overnight at 
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70°C, the rubber formed on the glass slide was cut into pieces of 0.5 cm × 0.5 
cm with thickness of about 0.5 mm. The silicone rubber was immersed in 
acetone and put in an ultrasonic bath for 2 min, followed by DI water rinsing 
and drying with a nitrogen flow to obtain clean rubber surface. 
The cleaned silicone rubber and sterile catheter segments with length of 1 
cm were immersed in polymer solution (10 mM Tris-buffered saline or 10mM 
PBS, pH 8.5) for 24 h at 70°C, and then rinsed with Tris-buffered saline three 
times before usage. 
4.2.4 Coating morphology and  thickness analysis by scanning electron 
microscopy   
After polymer coating at different concentrations as described in section 
4.2.3, the silicone slide was cut with a clean sharp blade. The coating surfaces 
and their cross-sections were then sputter-coated with platinum for 30 s, and 
imaged by a field emission scanning electron microscope (FE-SEM, JEOL 
JSM-7400F, Japan).  
4.2.5 Coating stability study under a simulated blood flow condition 
using X-ray photoelectron spectroscopy (XPS)  
After polymer coating as described in Section 4.2.3, the catheter segment 
was connected to a pump (Heidolph, Germany). The polymer-coated catheter 
segment was flushed using this pump with phosphate-buffered saline (PBS, 
pH 7.4) at the flow rate of 250 mL/min at 37°C to simulate the blood flow 
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condition. After PBS flushing for 7 days, the surface chemistry of the inner 
lumen of the catheter segment was tested by XPS (Kratos Axis HSi, Kratos 
Analytical, Shimadzu, Japan) with Al Kα source (hν = 1486.71 eV) in 
comparison with the uncoated catheter and polymer-coated catheter before the 
PBS flushing. The angle between the lumen surface and detector was kept at 
90°. The survey spectrum ranging from 1100-0 eV was acquired with pass 
energy of 80 eV.  
4.2.6 Quartz crystal microbalance with dissipation (QCM-D) 
measurements   
The coating of polymer 4b was monitored in real-time by QCM-D 
(Q-sense E4, Sweden). The same gold-coated AT-cut quartz crystals were used 
and cleaned as described in section 2.2.7. To generate a hydrophobic surface 
with similar wettability as silicone, a self-assembly monolayer of 
1-octadecanethiol (1-ODT) was fabricated.9 Clean gold-coated sensors were 
dipped into a solution of 1 mM 1-ODT in isopropanol for 18 hours. Then the 
substrates were rinsed in excessive isopropanol to remove the noncovalently 
bound thiol molecules. Finally, the substrate was dried with nitrogen gas. The 
obtained sensors were placed in the QCM-D chambers and rinsed with PBS 
(pH 8.5, 10mM) untill the frequency (f) and dissipation (D) were stabilized. 
After stable f and D baselines were obtained, polymer 4b with the 
concentration of 5 mg/ml in PBS was flown over the sensors at a flow rate of 
10 µL/min at room temperature. When equilibrium of the f and D was reached, 
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the heater in QCM-D was swiched on to gradually heat the chamber to 65 °C 
which is the highest temperature the QCM-D allows. After temperature 
reached 65 °C, the temperature was kept still till the end of the measurement. 
The recorded f and D at 3rd overtones were used for the analysis of the 
coating mechanism. 
4.2.7 Colony assay 
The concentration of bacteria (S. aureus and E. coli) in Mueller Hinton 
Broth (MHB) was adjusted to the optical density (OD) reading of 0.07 at the 
wavelength of 600 nm on a microplate reader (TECAN, Switzerland), which 
corresponds to the concentration of about 108 CFU/mL. The bacterial 
suspension was then diluted by 1000 times to the concentration of 105 
CFU/mL. The diluted bacterial suspension (10 μL) was added onto uncoated 
and polymer-coated silicone rubbers that were formed in a 48-well plate. After 
incubation at 35°C for 24 h, bacterial suspension was taken out from the 
rubber surface and diluted with an appropriate dilution factor. The diluted 
bacterial suspension was streaked onto an agar plate (LB Agar from 1st Base), 
and the number of the colony-forming units (CFUs) was counted after 
incubation for 18 h at 37°C. Each colony assay was carried out in triplicate.  
4.2.8 Testing of zone of inhibition  
In order to study the killing mechanism of polymer coatings, a modified 
Kirby Bauer disk diffusion method was used to assess the zone of inhibition. In 
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details, freshly grown bacteria S. aureus were diluted with MHB to approximate 
concentration of 3×108 CFU/mL. 10 µL of bacterial suspension was plated on 
LB agar growth plates. The polymer-coated surfaces and blank silicone were 
placed on top of the inoculated agar plates and incubated overnight at 37 ºC. 
Digital images of S. aureus colonies were captured. 
4.2.9 LIVE/DEAD bacterial viability assay 
Please refer to section 2.2.10 for the details of LIVE/DEA bacterial 
viability assay. The number of live and dead bacterial cells shown in green and 
red respectively in the images was analysed by the open-source software 
ImageJ (Fiji).10 
4.2.10 Hemolysis assay 
Please refer to section 2.2.13 for the details of hemolysis assay.   
4.2.11 Protein adsorption  
Micro BCA™ protein assay was used to determine the adsorption of a 
model protein bovine serum albumin (BSA) on polymer-coated surface. 
Pristine and polymer-coated silicone slides (10 mm ×10 mm ×0.5 mm) were 
immersed in 1 mL of PBS containing 5 mg/mL of BSA for 2 hours or 7 days at 
37˚C. Each sample was then rinsed three times with PBS, and subsequently 
placed in a glass vial with 1 mL of PBS containing 1 wt% of sodium dodecyl 
sulfate (SDS). The adsorbed BSA on the sample surfaces was removed by 
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sonicating the samples in the SDS solution for 30 min. The bicinhoninic acid 
(BCA) method was applied to quantify the amount of BSA in SDS by using 
Micro BCA™ protein assay reagent kit (Pierece, U.S.A.). The amount of BSA 
was calculated by measuring the absorbance at 562 nm. 
4.2.12 Analysis of platelet adhesion 
Please refer to section 2.2.12 for the details of analysis of platelet 
adhesion by using SEM 
4.3 Results and discussion 
4.3.1 Polymer synthesis and characterization 
The brush-like polycarbonates were synthesized by copolymerization of a 
cyclic carbonate monomer containing pendent benzyl chloride group 
(MTC-BnCl) with the other cyclic carbonate monomer containing pendent 
PEG group (MTC-PEG) (Scheme C1 in appendix C) using 4-methylbenzyl 
alcohol (4-MBA) as the initiator, and TU and DBU as co-catalysts to facilitate 
polymerization (Scheme 4.1A). The primary amine group of dopamine reacted 
with benzyl chloride in resultant polymers through nucleophilic substitution to 
incorporate dopamine in the polymers. The remaining pendent BnCl groups in 
the polymers were then quaternized with a large excess of trimethylamine 
(TMA), N,N-dimethylbutylamine or N,N-dimethylbenzylamine to obtain the 
final polymers with cations, PEG and dopamine. Detailed results and 
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discussion on the synthesis and characterization were shown in Appendix A. 
 
Scheme 4.1 (A) Synthesis procedures and structures of polycarbonates for 
catheter coatings. (B) The mussel-inspired adhesive catecholamine. (C) 
Schematic demonstration of one-step coating on silicone surface by using 
polymers containing adhesive, antibacterial and antifouling moieties.     
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4.3.2 Coating characterization and mechanism of thin film formation 
 
Figure 4.1 Characterization of pristine and polymer-coated silicone surfaces. 
(A) Color changes of surfaces, (B) contact angles, (C) high-resolution N1s 
XPS spectra and (D) surface morphology examined by SEM. 
 
                                                                    
109 
 
The polymers were coated onto silicone surfaces by immersing the 
surfaces in polymer solution (PBS, pH=8.5) with various concentrations at 70 
C for 24 h, and followed by rinsing with PBS. Similar to PDA coating, the 
colourless silicone rubber substrate turned brownish after treatment with 
polymers which containing dopamine (polymers 3a, 3b, 4a, 4b and 4c) 
(Figure 4.1 column A). In addition, surface characterization by contact angle 
measurement (Figure 4.1 column B) and XPS (Figure 4.1 column C) also 
indicates successful coating of polycarbonates with dopamine. After coating 
with polymers, surfaces turned hydrophilic from hydrophobic due to the 
presence of hydrophilic PEG and polycations in the polymers coated on the 
surfaces, and nitrogen in polymers coated on silicone surfaces resulted in the 
presence of nitrogen peak in XPS spectra. It is noted that no differences of 
contact angles measurement and XPS spectra were found for the surfaces 
before and after coating with polymer 1a which had no dopamine and PEG. 
This observation indicates this cationic homopolymer in aqueous solution was 
not able to be coated on silicone surfaces. Although the surfaces coated with 
polymer 2a which contained pendent PEG and cations displayed obvious 
changes on both contact angles results and XPS spectra after coating, the 
surface morphology shown in column D of Figure 4.1 demonstrated that only 
several isolated nanoparticles were randomly distributed on the surface instead 
of a uniform thin polymer film. This is probably resulted from the physical 
adsorption of polymer micelles. In comparison, surfaces coated with polymers 
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with both dopamine and PEG (i.e. 4a, 4b and 4c) provided better surface 
coverage, while polymers with dopamine and no PEG (polymer 3a and 3b) 
formed aggregates randomly on the surfaces.  
 
Figure 4.2 Transmittance of copolymer solution in function of temperature. (A) 




Figure 4.3 Transmittance of polymer 4b solution in function of temperature. 
The photograph in the left is the clear micelle solution, and the one in the right 
is the turbid vesicle solution. 
Due to the amphiphilic nature, copolymers (2a, 3a, 3b, 4a, 4b and 4c) 
formed micelles in aqueous solution at room temperature. This is the reason 
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why polymer could not be coated on silicone surfaces at room temperature, 
because the dopamine was encapsulated in the core of micelle, which made 
them not accessible for intermolecular crosslinking and adhesion on the 
silicone surfaces. Interestingly, when temperature increases to about 60ºC, a 
phase transition was observed for the polymers with dopamine and it is shown 
in Figure 4.2 and 4.3. For the copolymers with cationic carbonates and PEG 
but without dopamine (polymer 2a shown in Figure 4.2 A), no obvious 
decreasing of transmittance throughout the tested temperature was found, 
indicating no phase transition.    
 
 
Figure 4.4 Transmission electron microscopy (TEM) observations of different 
nanostructures of polymer 4b in solution at different conditions. Polymer 4b at 
room temperature (A), polymer kept at 70 ºC for 4 h (B) and polymer kept at 
70 ºC for 8h (C). (Scale bar: 50nm)  
 
Accompanying with the decreasing of transmittance, the clear lightly 
brown polymer solution turned to turbid shown in Figure 4.3, which suggests 
large nanoparticles or aggregates forming in the solution. However, the 
polymer 3a and 3b which are the copolymers with cationic carbonates and 
dopamine but without PEG, quickly formed large aggregates and precipitated 
down after the initial phase transition. These polymer solution on the top of 
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the testing vial then became clear and this led to increasing of the 
transmittance shown in Figure 4.2 B and C. This observation was in agreement 
with the SEM images of polymer 3a and 3b coating shown in column D in 
Figure 4.1, where many aggregates were found on the surfaces. Due to the 
formation of large aggregates, the coatings with polymer 3a and 3b were not 
uniform and unstable. In contrast, the colloid systems of polymers with cations, 
PEG and dopamine (4a, 4b and 4c) were relatively stable since no more 
changes were found in the plots of transmittance when the temperature kept 
increasing to 75 ºC. This observation suggests that the PEG is important for 
the stabilization of these polymer colloid systems. The hypothesis is that PEG 
as the most hydrophilic component in the polymers extended out from the 
micelle shell, and prevented the burst intermolecular cross-linking of 
dopamine and kept the reaction in a relatively controllable manner. The 
intermolecular cross-linking of dopamine resulted in a more hydrophobic 
micelle core and led to the formation of larger polymeric vesicles as shown in 
Figure 4.3 and 4.4. In Figure 4.4, a transition of polymer nanostructure from 
small micelle (~ 20 nm) to large hollow vesicle (>100 nm) was observed after 
incubation of polymers at 70 ºC, and the size of this vesicle became larger as 
incubation time increased. This is the reason why a sharp decrease of 
transmittance was observed for these polymers containing cations, PEG and 
dopamine.  
When intermolecular crosslinking continued for 24 h at 70 ºC, the 
                                                                    
113 
 
polymer with the highest dopamine content (4a) formed a network of 
cross-linked nanoparticles and was coated on silicone surfaces shown in 
Figure 4.1. Surprisingly, the polymer with moderate dopamine content (4b) 
formed a smooth thin polymer layer on silicone surfaces shown in column D 
of Figure 4.1. To explore how a polymer colloid solution formed a thin layer 
deposited on silicone surface, experiments of time-resolved SEM were 
conducted and the results were shown in Figure 4.5. Firstly, there were only a 
small number of small nanoparticles found on the surface after coating for 2 h. 
Then, more nanoparticles were observed and their size increased till 6 h. At 
the time point of 8 h, the number of nanoparticles suddenly decreased. 
Simultaneously, a thin film with the thickness of ~1 μm was found on the 
surface from the cross-section SEM image shown in column C of Figure 4.5 
After immersion of silicone surfaces in polymer 4b solution for 24 h, a smooth 
and uniform thin film was finally formed on silicone surfaces.         





Figure 4.5 SEM images of polymer 4b coating at different coating time points. 
Column A and B are the images with low (1k) and high (10k) magnification 
respectively, and the cross-section images were shown in column C.  
  
According to the SEM results, a mechanism was proposed that polymer 
4b vesicles went through a process including vesicle attachment, growth, 
rupture, fusion and finally formation of a polymer thin film on the surfaces. 
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This process was demonstrated in Scheme 4.2. To examine this hypothesis, the 
quartz crystal microbalance with dissipation (QCM-D) was used to monitor 
the coating process in real-time, and the results were shown in Figure 4.6.        
   
 
 
Scheme 4.2 Illustration of the proposed mechanism of polymer 4b thin film 
formation. 
 
Figure 4.6 Polymer coating characterized by quartz crystal microbalance with 
dissipation (QCM-D). Frequency shift (blue curve) and dissipation shift (red 
curve) of the 3rd overtone in function of time as temperature increased from 
room temperature to 65 ºC and then maintained at 65 ºC till the end of the 
measurement.  
 
In the QCM-D analysis, the frequency and dissipation shifts are 
proportional to the changes of surface mass and stiffness, respectively. As 
shown in Figure 4.6, frequency decreased from 0 to -20Hz when polymer was 
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pumped into QCM-D chamber, indicating that a few micelles adsorbed on 
surfaces. Then the frequency dramatically increased due to the ramping 
temperature resulting in the change of inherent resonance frequency of quartz 
crystals themselves. Therefore, no information of surface properties could be 
revealed in this stage. However, when the temperature stabilized at 65 ºC, the 
frequency decreased sharply from 155 Hz to -5 Hz instead of maintaining at 
155 Hz. The frequency decreasing suggests the mass dramatically increased 
on the surfaces due to the large vesicle deposition and their growth on the 
surfaces. When a critical coverage of adsorbed vesicles was reached at about 4 
h, the frequency started to increase. This is attributed to the releasing of water 
trapped inside of the vesicles as vesicles ruptured and fusion began on the 
surfaces. The decreasing of dissipation indicates that the film became more 
rigid resulting from water releasing, and this observation further confirmed the 
process of vesicle rupture and fusion. This process is similar to the classical 
two-step supported lipid bilayer formation on silicon oxide substrate.11 
Vesicles firstly adsorb on the substrate, and vesicle fusion begins when a 
critical coverage of vesicles is obtained, because vesicle-substrate interactions 
are insufficient to promote individual vesicle rupture. Once critical coverage 
of vesicles is obtained, the interactions of vesicle-vesicle and vesicle-substrate 
lead to the local vesicle rupture into patches, the edges of which further 
promote an autocatalytic support lipid bilayer formation. The QCM-D results 
are highly in agreement with observations from time-resolved SEM, and 
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suggest that the polymer 4b thin film formation went through a process 
including micelle-vesicle transition, vesicle attachment, growth, rupture, 
fusion and finally thin film formation.      
4.3.3 Antibacterial activities of polymer coatings 
Table 4.1 Minimal inhibitory concentrations (MICs, mg/L) of various 
polymers against S. epidermidis and S. aureus. 
 
Polymers 1a 2a 3a 3b 4a 4b 4c 
S. epidermidis 4 16 31 16 8 8 8 
S. aureus 16 31 62 31 16 31 31 
 
  
Figure 4.7 Antibacterial activities of polymer coatings against S. aureus and S. 
epidermidis. Bacteria colonies in bacterial suspension on the uncoated surface 
and surfaces coated with various polymers after 24 h of incubation. Solid 
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The bacteria most often isolated for the infected intravascular catheters 
are Gram-positive S. epidermidis and followed by S. aureus.12 Therefore, these 
two bacteria were used to test the antibacterial activities of the polymer 
coatings. Firstly, the antibacterial activities against S. epidermidis and S. 
aureus of the polymers in solution were evaluated by measuring their 
minimum inhibition concentrations (MICs). As shown in Table 4.1, all 
polymers displayed low MICs indicating the effective antibacterial activities 
against both bacteria. Moreover, cationic homopolymer possessed lower MICs 
than other copolymers, because the incorporation of dopamine or PEG could 
lower the overall charge density or hydrophobicity. However, when the 
polymers were coated on the surfaces, their antibacterial activities were 
significantly different from that in solution. As shown in Figure 4.7, only the 
surfaces coated with polymers (4a, 4b and 4c) which contain all three 
components (cations, PEG and dopamine) significantly reduced the number of 
both bacteria in bacterial suspension, and particularly the coatings of polymer 
4a and 4b were able to eradicate both bacteria in bacterial suspension. The 
different antibacterial activities of the polymers against these two bacteria are 
mainly due to the different coating qualities. Obviously, polymer 1a was not 
able to coat on silicone surface, and polymer 2a was coated on surfaces with 
only a very small number of polymeric micelles adsorbed on surfaces. In 
terms of polymers 3a and 3b, their nanoparticles aggregations were deposited 
on surfaces, but most of them were removed by the washing step resulting in 
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incomplete surface coverage as shown in Figure 4.1. In comparison, the 
coatings of polymer 4a and 4b provided perfect surface coverage by forming a 
cross-linked network of polymeric vesicles or a smooth thin film, thus 
completely eradicate bacteria in the suspension. The coating with polymer 4c 
displayed reduction of 99.99% and 99.9% against S. epidermidis and S. aureus 
respectively compared to pristine silicone surfaces. The imperfect killing 
efficacy is probably due to incomplete thin film formation and the presence of 
small cracks.      
 
Figure 4.8 Zone of inhibition observed for the pristine silicone surface (A) 
and surfaces coated with polymer 4a (B), 4b (C) and 4c (D) with incubation of 
S. aureus for 24 h. 
To determine whether the antibacterial effects are due to the releasing of 
antibacterial polymers from silicone surfaces or killing bacteria on contact, a 
modified Kirby Bauer disk diffusion method was used to observe the zone of 
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inhibition against S. aureus. In this method, if polymers were leached out from 
the surfaces and then killed bacteria in bacterial suspension, there would be a 
clear zone without any bacterial colonies in the vicinity of sample surfaces. 
However, the silicone surfaces coated with polymers 4a, 4b and 4c displayed no 
zone of inhibition as same as pristine silicone surface (Figure 4.8), 
demonstrating that the antibacterial activities of these polymer coatings are 
attributed to contact killing mechanism.    
4.3.4 Antifouling activities of polymer coatings 
 
Figure 4.9 Antifouling activities of polymer coatings against S. aureus and S. 
epidermidis. Bacterial metabolic activities on the uncoated surface and 
surfaces coated with various polymers after 24 h of incubation.  
 
To examine the bacterial adhesion and growth on pristine and 
polymer-coated silicone surfaces, a XTT assay which is a widely used method 
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and S. epidermidis for 24 h, surfaces coated with all the copolymers (2a, 3a, 
3b, 4a, 4b and 4c) exhibited significant reduction of bacterial viability on 
surfaces, and this was shown in Figure 4.9. In particular, the coatings of 
polymers 4a, 4b and 4c which contain all three components (cations, PEG and 
dopamine) displayed better antifouling activities with more than 95% and 90% 
reduction of bacterial viability on surfaces. Regarding to the antifouling 
activities of surfaces coated with polymer 2a, 3a and 3b, the reduction of 
bacterial viability could be due to the increased hydrophilicity after coating 
shown in Figure 4.1. Bacteria generally prefer to attach on hydrophobic 
surfaces. However, the incomplete surface coverage of these polymers leads to 
moderate reduction of bacteria on surfaces.   
To further confirm the antifouling properties of polymer-coated silicone 
surfaces, LIVE/DEAD bacterial viability assays were performed. In Figure 
4.10, a large number of live bacterial cells (green dots) were found on the 
uncoated silicone surfaces and polymer 1a treated surface after 24 h of 
incubation with S. aureus. However, there were much less live cells found on 
other polymers-coated silicone surfaces, indicating their good antifouling 
activity of the polymer coating. In particular, almost no live cell could be 
observed on the surfaces coated with polymers 4a, 4b and 4c. This observation 
is in good agreement with XTT assay findings. Notably, coating of polymer 4b 
exhibited the best antifouling activities among all the polymers tested probably 
due to the intact thin film formation on the surface. Although polymer 4a also 
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provided complete surface coverage, the excessive amount of dopamine could 
immobilize proteins and dead bacteria (red dot) shown in Figure 4.10. This is 
a potential risk for long-term application, since adsorbed dead cells or protein 
could mask the active polymer coatings. Therefore, polymer 4b was used for 
further optimization to kill and prevent fouling of Gram-negative bacteria.        
 
Figure 4.10 Live/dead cell staining of the uncoated silicone surface and the 
surfaces coated with various polymers after 24 h of incubation with S. aureus.  
 
4.3.5 Effects of quaternization agents 
Unfortunately, coating of polymer 4b failed to kill or prevent fouling of 
Gram-negative bacteria E. coli, which is the main organism contributing to the 
urinary catheter associated urinary tract infections.13 Recently, Willy et al. 
reported that the potency of polymer against Gram-negative bacteria was 
improved by using quaternization agents with long alkyl chain (i.e. number of 
carbon atom ≥4) or benzyl group due to the increasing of hydrophobicity. 
Therefore, N,N-dimethyl-butylamine and N,N-dimethyl-benzylamine instead 
of trimethylamine were employed for quaternization of 
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poly[(MTC-dopamine)4-ran-(MTC-OBnCl)60-ran-(MTC-PEG)10] to obtain 
polymers 4b’ and 4b’’, and their structures were shown in Scheme 4.1. 
Antibacterial activities of the polymers 4b, 4b’ and 4b’’against Gram-positive 
bacteria S. aureus and Gram-negative bacteria E. coli in solution were 
evaluated by measuring their MICs. As shown in Table 4.2, MICs values 
against E. coli decreased as the number of carbon atom in quaterization agents 
increased, confirming that the potency of the polymers containing cations, 
PEG and dopamine against Gram-negative bacteria could be improved by 
using more hydrophobic quaterization agents.        
 
Table 4.2 Minimal inhibitory concentrations (MICs, mg/L) of polymer 4b, 4b’ 
and 4b’’ against S. aureus and E. coli. 
 
Polymer S. aureus E. coli 
4b 32 500 
4b’ 16 125 
4b’’ 16 62.5 
 
To combat with the adhesion and growth of Gram-negative bacteria E. 
coli on silicone surfaces, polymer 4b’ and 4b’’ were coated onto silicone 
surfaces by immersing the silicone substrates in polymer solution (Tris buffer, 
pH 8.5) at 70 ºC for 24 h, and followed by rinsing with excessive Tris buffer. 
Similar to coating with polymer 4b, a thin layer of polymer 4b’ and 4b’’ could 
be coated on silicone surfaces and the surfaces properties were summarized in 
Figure 4.11. Contact angles of these polymer coatings shown in Figure 4.11 
were 47.6°±6.6° (4b), 72.6°±1.3° (4b’) and 70.7°±4.7° (4b’’), demonstrating 
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that the polymer coatings rendered hydrophilic silicone surfaces. Before 
treatment, silicone surfaces were hydrophobic with a contact angle of 
113.2°±0.6°. The new nitrogen peaks at 396.3 and 398.7 eV, which are 
attributed to the nitrogen in dopamine and cationic nitrogen in quaternary 
ammonium in the polymer repectively, further confirmed successful polymer 
coating. The cross-section SEM image reveals that the thickness of coatings 
with three different polymers on silicone surface was approximate 1 to 2 µm 
(Figure 4.11). The relatively thick coatings were due to the formation of 
polymer network induced by cross-linking of dopamine moieties in the 
polymers. 
 
Figure 4.11 Surface characterization of pristine silicone (A), polymer 4b (B), 
4b’ (C) and 4b’’ (D) coatings by high-resolution N (1s) XPS spectra, contact 
angle, and SEM. (cross-section of each polymer coating shown in the upper 
right corner). 
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The coating thickness can be modulated by varying the polymer 
concentration. For example, the thickness of polymer 4b’’ coating increased 
from about 120 nm to 1100 nm when the concentration increased from 0.1 
mM to 1.5 mM (Figure 4.12). The coating of 120 nm in thickness was uneven, 
where many cracks were observed possibly due to unmatched mechanical 
properties of coated polymer and silicone surfaces (Figure 4.12). Since the 
thicker polymer coatings had greater antibacterial activity (Figure 4.13), the 
relatively high polymer 4b’’ concentration of 1.5 mM was used for further 
studies.  
 
Figure 4.12 Surface morphology and cross-section SEM images (insets) of 
4b’’ coatings with different thickness by changing the concentration of 
polymer 4b’’ (a) 0.1 mM; (b) 0.5 mM; (c) 1.0 mM; (d) 1.5 mM. 




Figure 4.13 Antibacterial activities of polymer 4b’’ coating against 
Gram-positive S. aureus with different coating thickness. 
 
To evaluate the antibacterial and antifouling activities of polymer 
coatings, the number of bacteria in the bacterial suspension and the viability of 
bacteria attached on the surface were determined by agar plating and live/dead 
bacterial cell staining methods. The polymer-coated silicone surface was 
incubated with S. aureus or E. coli bacterial suspension for 24 h. The resulting 
bacterial suspension was then used for plating and followed with colony 
counting. As shown in Figure 4.14, polymer 4b, 4b’ and 4b’’ coatings 
effectively eradicated S. aureus in solution, and polymer 4b’ and 4b’’ coatings 
were able to kill E. coli with 99.9% and 99.999% reduction in bacterial counts, 
respectively, as compared with a pristine silicone rubber surface. The different 
antibacterial effects of these polymer coatings against Gram-negative E. coli 
might be due to different overall polymer hydrophobicity. Polymers with more 
hydrophobic quaternizing agents such as N,N-dimethyl-butylamine (4b’) and 
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polymer and lipid domains of E. coli membrane, leading to higher killing 
efficacy 14, 15.  
 
Figure 4.14 Effect of quaternizing agents on antibacterial and antifouling 
activities of polymer coatings against Gram-positive bacteria S. aureus and 
Gram-negative bacteria E. coli. (A) Colony-forming units (CFUs) of S. aureus 
and E. coli in the bacterial suspension after 24 h of incubation with the pristine 
and polymer-coated silicone surfaces; (B) Confocal images of S. aureus and E. 
coli on the pristine and polymer-coated after 24 h of incubation. E. coli cells 
were stained using LIVE/DEAD BacLight Bacterial Viability Kits. The green 
and red regions represent live and dead cells, respectively; (C) The number of 
live and dead E. coli cells on the untreated and polymer-coated silicone 
surfaces. 
 
Apart from antibacterial activity, antifouling activity of these polymer 
coatings was tested with live/dead bacterial staining. As shown in Figure 4.14 
B and C, very few, if any, live S. aureus bacterial cells (green dots in Figure 
4.14 B) were observed on the polymer-coated surfaces, whereas a large 
amount of live cells could be found on the control pristine silicone surface. 
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Although many live E. coli cells could be found on polymer 4b coating, only 
few live E. coli cells were observed on 4b’ and 4b’’ coatings. From the 
quantification results shown in Figure 4.14 C, less live cells were on the more 
hydrophobic polymer 4b’ and 4b’’-coated surfaces. In particular, less than 100 
live E. coli cells/mm2 were found on polymer 4b’’ coating, while over 2.5 ×
105 live E. coli cell/mm2 were observed on the control surface. These findings 
demonstrate that the antibacterial and antifouling activities against the 
Gram-negative bacteria E. coli were enhanced by the usage of more 
hydrophobic quaternizing agents. 
4.3.6 Long-term stability 
Since the indwelling time of intravascular catheters can be as long as 5 
days or more,16 the stability and long-term activities of the best polymer 
coating (i.e., 4b’’coating) were examined. To mimic the intravascular blood 
flow conditions, 4b’’-coated catheter tubes were flushed with 
phosphate-buffered saline (PBS, pH 7.4) at the flow rate of 250 mL/min at 37 
C for 7 days. After flushing, the color of polymer-coated catheter was still  
brown same as that before flushing, indicating the presence of polymer 4b’’ 
after flushing. Moreover, the chemical composition of the catheter surface 
before and after PBS flushing was tested by XPS. From the XPS spectra 
shown in Figure 4.15 B, the nitrogen peak at 396 eV from the polymer was 
still seen even after flushing for one week. In addition, the nitrogen content 
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displayed insignificant difference from 2.0% before flusing to 1.8% after 
flushing.. Furthermore, both nitrogen peaks remained similar in the 
high-resolution N(1s) XPS spectrum of the 4b’’ coating after flushing (Figure 
4.15 C vs. Figure 4.11 D). These results suggest that this polymer coating is 
robust and the polymers could remain on the catheter surfaces even after 7 
days of PBS flushing. The long-term antibacterial and antifouling activities of 
the 4b’’ coating were evaluated over 2 weeks by adding a fresh bacterial 
suspension (105 CFU/mL) to the 4b’’-coated rubber surface every 24 hours. 
The 4b’’ coating, which was formed at the concentration of 1.5 mM, was able 
to eradicate S. aureus in the solution even after 14 days of incubation (Figure 
4.16 A), and importantly, no bacterial cells were found on the 4b’’-coated 
surface (Figure 4.16 B).  
 
Figure 4.15 Stability of polymer 4b’’ coating. (A) Photographs of an untreated 
silicone catheter and 4b’’-coated catheter surfaces before and after flushing by 
simulated blood flow for 7 days. (B) XPS spectra of the untreated catheter and 
4b’’-coated catheter surfaces before and after flushing. (C) High-resolution 
N(1s) XPS spectrum of polymer 4b’’ coating after flushing. 
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Figure 4.16 Long-term antibacterial and antifouling activities of the 4b’’ 
coating (A) Colony-forming units (CFUs) of S. aureus in the solution after 
being in contact with the untreated silicone and the silicone coated with 4b’’ at 
1.5 mM over different periods of time. A fresh bacterial suspension (105 
CFU/mL) was added to the surfaces every 24 h. Solid circles indicate no 
colony found; (B) Confocal images of S. aureus on the untreated silicone 
surface and the surface coated with 4b’’ at 1.5 mM after 14 days. 
 
4.3.7 Hemocompatibility 
As a coating on catheters which could have frequent contacting with blood, 
the hemocompatibilty of the coating is very important. Therefore, the 
hemolysis of 4b’’ coating was evaluated. Hemolysis assay which examines the 
hemoglobin release due to rupturing of red blood cells is a commonly-used 
method to evaluate the toxicity of polymer coatings. As shown in Figure 4.17, 
the polymer coating fabricated under various concentrations induced no 
significant hemolysis due to the presence of biocompatible PEG and dopamine 
components in 4b’’. No releasing of antibacterial polymers from the surface 
could also be an important reason for the non-hemolytic activity. In addition, 
protein adsorption on the 4b’’-coated surface was assessed, because there is a 
large amount of proteins existing in the blood, and protein adsorption may 
mask the antibacterial and antifouling activities of polymer coating. The mass 
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of bovine serum albumin (BSA) adsorbed on the pristine silicone surfaces 
were 0.86 µg/cm2 and 1.68 µg/cm2 at the immersion time of 2 hours and 7 days, 
respectively (Figure 4.18 A). Meanwhile, the mass of BSA adsorbed on 
polymer 4b’’-coated silicone surfaces dramatically decreased to 0.06 µg/cm2 
and 0.12 µg/cm2, respectively. The antifouling of polymer 4b’’ coating against 
BSA adsorption is probably due to the increase of surface hydrophilicity17 and 
the presence of PEG molecules. The good antifouling activities are very 
important, since protein adsorbed on surface could act as conditioning film to 
accommodate bacteria and provide nutrient for their growth. Moreover, it is 
essential to prevent the formation of thrombus as catheter coatings frequently 
contact with blood. Unlike the pristine rubber surface, the 4b’’-coated surface 
was not thrombogenic, since no platelet adhesion was observed on the coated 
surface (Figure 4.18 B and C).  
 
Figure 4.17 Hemolysis evaluation of the silicone rubber surface coated with 
polymer 4b’’ at various concentrations. 




















Figure 4.18 Hemocompatibility of polymer 4b’’ coating. (A) Evaluation of 
bovine serum albumin (BSA) adsorption on 4b’’ coating by Micro BCA™ 
protein assay; SEM images of platelet adhesion on pristine silicone surface (B) 




In conclusion, the brush-like polycarbonates with three important 
components, i.e. antibacterial cations, antifouling PEG and adhesive dopamine, 
have been successfully synthesized and coated onto a catheter surface by a 
simple one-step immersion. The polymers without dopamine or PEG were not 
able to form a uniform polymer coating with complete surface coverage. The 
polymer 4b which contains cations, PEG and four repeat units of dopamine 
moieties could form an intact thin film on silicone surfaces, and displayed 
excellent antibacterial and antifouling activities against Gram-positive bacteria 
S. aureus and S. epidermidis. The thin film formation involved several steps 
including a transition of polymeric micelle to vesicle, vesicle attachment, 
growth, rupture and fusion on the surfaces. By changing quaternization agent 
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in the last step of polymer synthesis, the potency of the polymer could be 
improved. Coating with polymer quaternized with more hydrophobic agent, 
was able to kill both Gram-positive and Gram-negative bacteria in suspension 
and prevent their fouling on the catheter surfaces. In addition, this polymer 
coating was stable under a simulated blood flow, and its antibacterial and 
antifouling activities remained even after being in contact with bacterial 
suspension over a long period of time. Importantly, this coating was 
hemocompatible, and able to prevent protein adsorption and platelet adhesion. 
These properties are essential for the blood-contacting materials. Therefore, 
these brush-like polymers have great potential for application as coatings of 
intravascular catheters to prevent CAIs. 
  




1. X. Ding, C. Yang, T. P. Lim, L. Y. Hsu, A. C. Engler, J. L. Hedrick and 
Y.-Y. Yang, Biomaterials, 2012, 33, 6593-6603. 
2. J. L. Dalsin, B.-H. Hu, B. P. Lee and P. B. Messersmith, J. Am. Chem. 
Soc., 2003, 125, 4253-4258. 
3. H. Han, J. Wu, C. W. Avery, M. Mizutani, X. Jiang, M. Kamigaito, Z. 
Chen, C. Xi and K. Kuroda, Langmuir, 2011, 27, 4010-4019. 
4. L. A. Mermel and N. Alang, J. Antimicrob. Chemother., 2014, dku182. 
5. H. Lee, S. M. Dellatore, W. M. Miller and P. B. Messersmith, Science, 
2007, 318, 426-430. 
6. S. M. Kang, J. Rho, I. S. Choi, P. B. Messersmith and H. Lee, J. Am. 
Chem. Soc., 2009, 131, 13224-13225. 
7. K. Kim, J. H. Ryu, D. Y. Lee and H. Lee, Biomater. Sci., 2013, 1, 
783-790. 
8. J. P. Park, M.-J. Choi, S. H. Kim, S. H. Lee and H. Lee, Appl. Environ. 
Microbiol., 2013, AEM. 02223-02213. 
9. R. B. Pernites, M. J. L. Felipe, E. L. Foster and R. C. Advincula, ACS 
Appl. Mater. Interfaces, 2011, 3, 817-827. 
10. J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. 
Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld and B. Schmid, Nat. 
Methods, 2012, 9, 676-682. 
11. N.-J. Cho, C. W. Frank, B. Kasemo and F. Höök, Nat. Protoc., 2010, 5, 




12. R. M. Donlan, Emerg. Infect. Dis., 2001, 7, 277. 
13. E. Woods and S. L. Percival, Biofilms in Infection Prevention and 
Control: A Healthcare Handbook, 2014, 185. 
14. Y. Qiao, C. Yang, D. J. Coady, Z. Y. Ong, J. L. Hedrick and Y.-Y. Yang, 
Biomaterials, 2012, 33, 1146-1153. 
15. M. F. Ilker, K. Nüsslein, G. N. Tew and E. B. Coughlin, J. Am. Chem. 
Soc., 2004, 126, 15870-15875. 
16. K. H. Polderman and A. R. Girbes, Intensive Care Med., 2002, 28, 
1-17. 
17. D. Rana and T. Matsuura, Chem. Rev., 2010, 110, 2448-2471. 
 
  
                                                                    
136 
 
Chapter 5. Conclusion and Future Perspectives 
1.1 Conclusion 
The common thread linking the different chapters of this thesis together, 
is the overall goal of modifying catheter surfaces by coating them with 
antibacterial and antifouling polymers to kill bacteria, and inhibit their 
adhesion and subsequent biofilm formation. To obtain facile, biocompatible 
and effective anti-infective coating systems, the antibacterial cationic 
polycarbonates, antifouling PEG and mussel-inspired adhesive dopamine/PDA 
were combined by using different approaches to generate antibacterial and 
antifouling surfaces. 
As reported in Chapter 2, the diblock copolymers of PEG-b-cationic 
polycarbonates synthesized by metal-free organocatalytic ring-opening 
polymerization were successfully grafted onto silicone rubber surfaces through 
a two-step process: (1) a thin film of PDA self-polymerized from dopamine 
was formed on silicone surfaces; (2) the polymers were then grafted on the 
PDA layer via the Michael addition between PDA and the thiol group on the 
distal end of PEG in the polymers.1 These polymer coatings with a 
hydrophobic component killed S. aureus, including MRSA, in bacterial 
suspension and efficiently prevented their fouling on surfaces. The high killing 
efficiency of this polymer with hydrophobic components indicates that 
polymer hydrophobicity is important to render an antibacterial surface. In 
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addition, surfaces coated with polymers containing more hydrophobic contents 
showed a higher antifouling activity than PEG-coated surfaces, probably due 
to the synergistic effects of antibacterial and antifouling effects. Furthermore, 
these coatings inhibited biofilm formation without causing significant 
hemolysis, blood protein adsorption or platelet adhesion. These findings 
suggest the great potential of PEG-b-cationic polycarbonates as an 
antibacterial and antifouling polymers for intravascular catheter coating. 
However, the aforementioned coating was not effective against Gram-negative 
bacterial, such as E. coli which is the main organism responsible for urinary 
catheter-associated infections.   
To improve the above coating system, a PEG-based antimicrobial 
hydrogel using the same polymers described in Chapter 2, was coated onto the 
silicone surfaces.2 PDA was first coated on silicone surfaces, followed by 
grafting of the thiol-containing tetra-sulfhydryl PEG on the PDA layer. 
Subsequently, a hydrogel coating layer was formed in situ on the silicone 
surface with the addition of tetra-acrylate PEG conjugated with 
PEG-b-cationic polycarbonates. This hydrogel exhibited excellent 
antibacterial activities against both Gram-positive bacteria S. aureus and 
Gram-negative bacteria E. coli through a contact based killing mechanism. In 
addition, the antifouling activities of this hydrogel to prevent bacterial 
adhesion were superior to hydrogel with only the PEG network, and the 
nonfouling properties could be maintained for a long period of time.   
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To further simplify the coating process, brush-like polycarbonates with 
three key components, i.e. antibacterial cations, antifouling PEG and adhesive 
dopamine were designed to create a one-step catheter coating method as 
reported in Chapter 4. The polymers without dopamine or PEG were found not 
able to form a uniform polymer coating on silicone surfaces. Meanwhile, 
polymer which contains cations, PEG and four repeat units of dopamine, could 
form an intact thin film on silicone surfaces, and displayed excellent 
antibacterial and antifouling activities against Gram-positive bacteria S. aureus 
and S. epidermidis. The mechanism of the formation thin film was studied, 
and it was found that it involved several steps, including a transition of 
polymeric micelle to vesicle, vesicle attachment, growth, rupture and fusion 
on the surfaces, to form the thin film on the silicone surfaces. By changing the 
quaternization agent in the last step of polymer synthesis, the broad-spectrum 
antibacterial activities against both Gram-positive and Gram-negative bacteria 
(i.e. S. aureus and E. coli) were obtained for the coating with polymer 
quaternized with a more hydrophobic agent. In addition, this polymer coating 
was stable under simulated blood flow condition, and its antibacterial and 
antifouling activities remained even after being in contact with bacterial 
suspension over two weeks. Moreover, this coating was hemocompatible. 
Therefore, this brush-like polymer has great potential for use as an 
anti-infective catheter coating for prevention of CAIs. 
In conclusion, the findings covered by this thesis have shown strong 
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evidence to support the hypothesis that facile, biocompatible and effective 
anti-infective polymer coatings on inert catheter surfaces can be obtained 
through incorporating antibacterial cations, antifouling PEG and 
mussel-inspired adhesive dopamine/PDA in the coating systems. Importantly, 
several simple and inexpensive approaches to coat the antibacterial and 
antifouling polymers on the surfaces have been developed for prevention of 
CAIs. In addition, these approaches may not be limited to only use in catheter 
coatings, but could also potentially find wide-scale applications as coatings for 
various medical devices, such as vascular stents and contact lens. More 
importantly, this study has taken the first step in examining the synergistic 
effects between antibacterial and antifouling molecules, suggesting that it is 
necessary to incorporate both antibacterial and antifouling features in the 
coating system to maintain long-term anti-infective effectiveness. Moreover, 
this study has provided insight into the coating mechanisms of block 
copolymers containing dopamine or its analogues, and shed a light on the 
design of such polymers.  
 
1.2  Future perspectives 
Although the findings in this thesis upheld the stated hypothesis, further 
investigations are still needed to validate the potential practicality of the 
aforementioned polymer coatings.  
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Firstly, catheters come in contact with the blood flow and thus testing of 
coatings under flow condition is very important. The stability of polymer 
coatings under the simulated blood flow conditions has been studied and the 
robustness of coating under such conditions has been confirmed. However, all 
the antibacterial and antifouling tests used in this study were carried out under 
static conditions instead of flow condition. A parallel plated flow chamber 
which allows insertion of removable discs 3 could be used to test the 
antibacterial and antifouling polymer coatings under variable flow conditions, 
and the effects of shear stress on their activity should be studied. In addition, 
protein adsorption and platelet adhesion on surfaces coated with polymers 
could be also assessed via the use of the aforementioned parallel plated flow 
chambers. 
Secondly, the antibacterial mechanism (disruption/leakage of cell 
membranes) for polymer coatings should be confirmed by SEM and 
cryo-TEM studies. Although SEM and cryo-TEM have been used to study the 
disruption/leakage mechanism of cationic antimicrobial polycarbonates in 
solution by observing the morphology of bacterial membranes,4,5 the killing 
mechanism for the immobilized antimicrobial polymers might not be totally 
the same as polymers in solution. It is better to further confirm the killing 
mechanism of immobilized antimicrobial polymer using SEM and Cryo-TEM.    
Thirdly, although in vitro tests of antibacterial and antifouling activities 
have been carried out in this study, the anti-infective efficacy of polymer 
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coatings needs to be examined in vivo to confirm their potential for clinical 
applications. A few animal models were reported to evaluate the effects of 
antimicrobial agents on S. aureus biofilm development on the surfaces of 
vascular catheters.6, 7 The rat central venous catheter biofilm model6 could be 
adopted to test the effectiveness of polymer coatings on catheter surfaces. By 
observing biofilm morphology by SEM and counting CFU on catheter 
surfaces, in vivo antibacterial and antifouling activities of polymer coatings in 
vivo could be revealed. In addition, the polymer might degrade if the polymer 
coating is placed in the body for long time. It is necessary to test if degraded 
polymer fragments, if any, are toxic to animals or not.  
The findings of this study uncover further possibilities of using polymers 
containing antibacterial cations, antifouling PEG and adhesive dopamine, as 
described in Chapter 4. Due to the positive charge and relatively large 
thickness (1µm) of the polymer coating, it could serve as a matrix to load a 
large amount of antimicrobial agents carrying a negative charge (e.g. penicillin 
and cephalosporin) onto surfaces. The coating with controlled release of 
antimicrobial agents may be applied on urinary catheters to prevent biofilm 
formation, and simultaneously act as a promising therapeutic approach. In 
addition, due to the reactivity of dopamine, growth factors or other functional 
proteins can be bound onto surfaces which have been coated with antibacterial 
and antifouling polymers containing an excessive amount of dopamine, as 
described in Chapter 4. This post-treatment on the antibacterial surface could 
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potentially provide more surface functions in addition to antibacterial activity, 
giving rise to a platform to obtain multifunctional coatings for a variety of 
medical devices.  
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Appendix A: Synthetic procedures and characterization of 
PEG-b-cationic polycarbonate diblock copolymers 
A1. Methods 
Polymer Synthesis 
In a glove-box, 0.3 g (0.06 mmol) of HS-PEG-OH initiator, 0.338 g (1.2 
mmol) of MTC-OPrBr (for a target degree of polymerization (DP) of 20), and 
0.113 g (0.6 mmol) of MTC-OEt (for a target DP of 10) were charged in a 20 
mL glass vial equipped with a stir bar. Dichloromethane was added and the 
concentration was adjusted to 2 M with respect to the monomer. Once the 
intiator and monomers were completely dissolved, 22.2 mg (0.06 mmol) of 
TU and 9 L (0.06 mmol) of DBU were added to catalyze the polymerization. 
After five hours, 5-10 mg of benzoic acid was added to quench the 
polymerization, after which the crude product was taken out off the glove-box, 
and purified by column chromatography on a Sephadex LH-20 column with 
THF as eluent. Then a colorless and sticky liquid (0.7g, 93%) as polymer 2 
precursor (HS-PEG-b-[P(MTC-OPrBr)18-r-P(MTC-OEt)10] was obtained. PDI: 
1.19. 1H NMR (400 MHz, CDCl3, 22 °C):  4.31 (m, 168H, H of –CH2OCOO- 
and -OCH2-), 3.65 (s, 455H, H of -PEG-), 3.47 (t, 36H, -CH2Br), 2.19 (m, 36H, 
-CH2CH2Br), 1.27 (m, 60H, -CH3). 
The resultant polymer (0.7 g, ~0.06 mmol) was dissolved in acetonitrile 
(50 mL) and the solution was transferred (under nitrogen) into a 100 mL 
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pressure safe Schlenk tube equipped with a stir bar. Under nitrogen the 
solution was cooled with dry ice, after which trimethylamine (~0.5 g) was 
condensed into the Schlenk tube that was then sealed. The solution was held 
overnight under stirring. Following the reaction, the solution was cooled to 
ambient temperature and nitrogen was bubbled through to remove excess 
trimethylamine. The solvent was removed by rotational evaporation, and the 
obtained product was dried in a vacuum oven until a constant weight was 
reached (0.76 g, ~100%). 1H NMR (400 MHz, DMSO-d6, 22 °C):  4.07-4.25 
(m, br, 168H, H of -CH2OCOO- and -OCH2-), 3.39 (s, 491H, H of -CH2N- 
and -PEG-), 3.06 (s, 162H, -NCH3), 2.03 (s, 36H, -CH2CH2N-), 1.14 (m, 
60H, -CH3). 
Polymer 1 precursor (HS-PEG-b-[P(MTC-OPrBr)18-r-P(MTC- OEt)26]), 
PDI: 1.23; Yield, 0.83 g, 90%. 1H NMR (400 MHz, CDCl3, 22 °C):  4.30 (m, 
264H, H of -CH2OCOO- and -OCH2-), 3.63 (s, 455H, H of -PEG-), 3.44 (t, 
36H, -CH2Br), 2.18 (m, 36H, -CH2CH2Br), 1.27 (m, 210H, -CH3). 
Polymer 1, Yield, 0.88 g, ~100%. 1H NMR (400 MHz, DMSO-d6, 22 °C):  
4.08-4.26 (m, br, 264H, H of -CH2OCOO- and -OCH2-), 3.50 (s, 491H, H of 
-CH2N- and -PEG-), 3.06 (s, 162H, -NCH3), 2.04 (s, 36H, -CH2CH2N-), 
1.16 (m, 210H, -CH3). 
Polymer 3 precursor (HS-PEG-b-P(MTC-OPrBr)18), PDI: 1.26; Yield, 0.60 
g, 94%. 1H NMR (400 MHz, CDCl3, 22 °C):  4.29 (m, 108H, H of –
CH2OCOO- and -OCH2-), 3.64 (s, 455H, H of -PEG-), 3.45 (t, 36H, -CH2Br), 
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2.19 (m, 36H, -CH2CH2Br), 1.27 (m, 54H, -CH3). 
Polymer 3, Yield, 0.88 g, ~100%. 1H NMR (400 MHz, DMSO-d6, 22 °C):  
4.12-4.31 (m, br, 108H, H of -CH2OCOO- and -OCH2-), 3.51 (s, 491H, H of 
-CH2N- and -PEG-), 3.10 (s, 162H, -NCH3), 2.06 (s, 36H, -CH2CH2N-), 
1.20 (m, 54H, -CH3). 
Polymer characterizations 
Gel permeation chromatography (GPC) 
GPC analysis of block copolymers was carried out with a Waters HPLC 
system equipped with a 2690D separation module, two Styragel HR1 and 
HR4E (THF) 5 m columns (size: 300 × 7.8 mm) in series and a Waters 410 
differential refractometer detector. The mobile phase used was THF with a 
flow rate of 1 mL/min. Number-average molecular weights as well as 
polydispersity indices were calculated from a calibration curve using a series 
of polystyrene standards with molecular weight ranging from 1,350 to 
151,700. 
1H NMR analysis 
1H NMR spectra of monomers and polymers were recorded on a Bruker 
Advance 400 NMR spectrometer at 400 MHz at room temperature. The 1H 
NMR measurements were carried out with an acquisition time of 3.2 s, a pulse 
repetition time of 2.0 s, a 30° pulse width, 5208-Hz spectral width, and 32 K 
data points. Chemical shifts were referred to the solvent peaks (δ = 7.26 and 
2.50 ppm for CDCl3 and DMSO-d6, respectively). 
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A2 Results and discussion on the synthesis and characterization of 
PEG-b-cationic polycarbonate diblock copolymers 
Polymer precursors with various compositions were synthesized by 
organocatalytic ring-opening polymerization (ROP) of two functional cyclic 
carbonates MTC-OEt and MTC-PrBr, as shown in Scheme 2.1.  
The living and highly controlled nature of organocatalytic ROP method 
provided polymer compositions that matched well with initial 
monomer/initiator feed ratios. In Figure A.1A, 1H NMR analysis of the 
polymer 2 precursor showed that all peaks attributed to HS-PEG, carbonates 
with OEt and OPrBr pendent groups were observed. Moreover, there was very 
good correlation between polymer integration values and original monomer 
concentrations. Since MTC-OEt and MTC-OPrBr had similar reactivity, it was 
assumed that both monomers were dispersed randomly throughout the 
polymeric chain. All the polymer precursors had narrow molecular weight 
distribution with polydispersity index (PDI) values ranging from 1.19 to 1.26. 
After isolation and purification, the polymer precursors were dissolved in 
anhydrous acetonitrile, and reacted with excess trimethylamine (TMA) in a 
pressure vessel. Finally, cationic polymers 1, 2 and 3 with a thiol functional 
group on the distal end of PEG were obtained and dried in vacuo after 
removing all the solvent and excess TMA. By 1H-NMR (Figure A.1B, 
polymer 2), a new peak at 3.06 ppm was clearly observed, which was 
attributed to the proton peak of methyl groups adjacent to the new C-N bond. 
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By comparing the integration of this peak with the peak at 2.03 ppm (H of 
-CH2CH2N moiety), it is found that almost all the PrBr pendent groups in the 
polymer were aminated by TMA.   
 
Figure A.1. 1H NMR spectra of polymer 2 precursor in CDCl3 (A) and 
polymer 2 in DMSO-d6 (B). 
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Appendix B: Evaluation methods of hydrogels formed in situ from 
polycarbonate and PEG via Michael addition 
Characterization of hydrogels 
The gelation time was determined by the vial tilting method. When the 
sample showed no ability to flow, it was regarded as a gel. The gels were 
subsequently incubated in DI water and allowed to swell, and weighted at 
various time intervals until a constant weight was observed. All samples were 
analyzed in triplicate. Rheology experiments were performed at room 
temperature using a control-strain rheometer (ARES G2, TA instruments). The 
rheometer is equipped with two sensitive force transducers for torque ranging 
from 0.05 N.m to 200 mN.m. The swollen gel was placed onto parallel-plate 
geometry (8 mm in diameter). The dynamic storage modulus (G) and loss 
modulus (G) of the gel were examined as a function of frequency from 1 to 
100 rad/s. The measurements were carried out at a strain amplitude (g) of 5% 
to ensure the linearity of viscoelasticity.  
Antimicrobial assays 
Hydrogels for the antimicrobial assays were prepared in 96-well tissue 
culture plates (NUNC). 50 μL of hydrogel precursor solution was transferred 
to the wells. Gelation occurred in minutes at 37˚C. The bacteria were grown in 
tryptic soy broth (TSB, BD) overnight in an incubator at 37˚C. It is noted that 
C. albicans cells were grown in yeast medium broth (YMB, BD) at room 
temperature. The optical density of the bacterial suspension was adjusted to 
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OD600 nm = 0.07 by the addition of TSB or YMB. This yielded a microbial 
stock solution with approximated 3.5×108 colony-forming units (CFU)/mL. 
The minimum inhibitory concentrations (MICs) of polymers were measured 
using a broth microdilution method.1 Briefly, 100 μL of polymer solution was 
introduced into each well of a 96-well plate followed by the addition of 100 
μL of the miroorganism suspension with 5.0×105 CFU/mL. The optical density 
readings of miroorganism suspensions were monitored by measuring OD 600 nm 
0 and 18 h. The MIC was taken at the concentration at which no growth was 
observed with the microplate reader (TECAN Instruments). Broth containing 
cells only was used as control. The growth of microorganism on hydrogel was 
also measured using a broth dilution method. Briefly, 50 μL of miroorganism 
solution with 3.5×108 CFU/mL was introduced onto the hydrogels, and tissue 
culture 96-well plate and PEG hydrogel were used as controls. The optical 
density readings of bacterial suspension were monitored by measuring OD600 
nm. The assay was performed in four replicates for each sample and the 
experiments were repeated at least three times. Antimicrobial activities have 
been further tested through a spread plate method. Briefly, hydrogels were 
challenged with miroorganism solution, at predetermined times, microbial 
suspensions were withdrawn and diluted sequentially, and then plated on 1.5% 
LB agar plates. The plates were incubated for 24 h at 37˚C (48 h at room 
temperature for C. albicans). Microbial colonies were formed and counted. 
The results are expressed as %kill = (cell count of PEG gel-survivor count of 
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sample)/cell count of PEG gel×100. The experiments were performed in 
triplicate and were repeated three times. 
Scanning electron microscopy  
The bacteria grown in broth alone and on the surface of hydrogels were 
harvested after 2 h of incubation by centrifugation at 4000 rpm for 5 min. 
They were washed 3 times by PBS and then fixed in formalin solution 
containing 4% formaldehyde for two days. The cells were further washed with 
DI water, followed by dehydration using a series of ethanol solutions with 
different volume contents (35%, 50%, 75%, 90%, 95% and 100%). The 
bacterial sample was placed on a carbon tape, which was further coated with 
platinum. The morphologies of the bacteria before and after treatment were 
observed using a field emission SEM (JEOL JSM-7400F) operated at an 
accelerating voltage of 10.0 kv and working distance of 8.0 mm. 
Acute dermal toxicity 
Study guidelines: Organisation for Economic Co-operation and 
Development (OECD) Guideline for Testing of Chemicals 402: Acute Dermal 
Toxicity, adopted on 24th February 1987; Globally Harmonized System of 
Classification and Labeling of Chemicals (GHS), second revised edition, 
United Nations, New York and Geneva, 2007, Part 3, Health Hazards, Chapter 
3.1: Acute Toxicity. 
10 Wistar rats (5 female: 232-285 g; 5 male: 402-522 g; 9-13 weeks old) 
were taken from the Centre for Animal Resources, National University of 
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Singapore, and housed in the OptiMICE Caging Systems for rats 
(Temperature: 18-22°C; Humidity: 30-70%). The rats were acclimatized for at 
least 5 days prior to the test. Approximately 24 hours before the test, fur in the 
dorsal area of each rat’s trunk was removed. The shaved area was not less than 
10% of the body area. On the dosing day, the rats were weighed prior to 
dosing. The hydrogel was administered topically and uniformly on the shaved 
area of each rat. The hydrogel was held in contact with the skin using a gauze 
patch secured by occlusive dressing. The dose level was 2000 mg/kg based on 
the body weight of each rat, and the exposure was for 24 hours. Observations 
of adverse effects were conducted periodically up to 14 days, and the body 
weight of each rat was measured every 3-7 days. Based on the results and 
Global Harmonised Classification System for acute toxicity hazard categories, 
the acute dermal toxicity of the hydrogel is considered as Category 5 or 
unclassified; LD50 value of the hydrogel is more than 2000 mg/kg body 
weight. 
Acute dermal toxicity  
Study guidelines: Organisation for Economic Co-operation and 
Development (OECD) Guideline for Testing of Chemicals 402: Acute Dermal 
Toxicity, adopted on 24th February 1987; Globally Harmonized System of 
Classification and Labeling of Chemicals (GHS), second revised edition, 
United Nations, New York and Geneva, 2007, Part 3, Health Hazards, Chapter 
3.1: Acute Toxicity. 10 Wistar rats (5 female: 232-285 g; 5 male: 402-522 g; 
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9-13 weeks old) were taken from the Centre for Animal Resources, National 
University of Singapore, and housed in the OptiMICE Caging Systems for rats 
(Temperature: 18-22°C; Humidity: 30-70%). The rats were acclimatized for at 
least 5 days prior to the test. Approximately 24 hours before the test, fur in the 
dorsal area of each rat’s trunk was removed. The shaved area was not less than 
10% of the body area. On the dosing day, the rats were weighed prior to 
dosing. The hydrogel was administered topically and uniformly on the shaved 
area of each rat. The hydrogel was held in contact with the skin using a gauze 
patch secured by occlusive dressing. The dose level was 2000 mg/kg based on 
the body weight of each rat, and the exposure was for 24 hours. Observations 
of adverse effects were conducted periodically up to 14 days, and the body 
weight of each rat was measured every 3-7 days. Based on the results and 
Global Harmonised Classification System for acute toxicity hazard categories, 
the acute dermal toxicity of the hydrogel is considered as Category 5 or 
unclassified; LD50 value of the hydrogel is more than 2000 mg/kg. 
Skin irritation  
Study guidelines: ISO 10993 Biological Evaluation of Medical Devices – 
Part 10: Tests for Irritation and Delayed-type Hypersensitivity. Second Edition 
(2002-09-01); Second Edition (2002- 09-01): Amendment 1 (2006-07-15); 
Third Edition (2010-08-01); ISO 10993 Biological Evaluation of Medical 
Devices – Part 12: Sample Preparation and Reference Materials. Third Edition 
(2007-11-15). Three New Zealand white rabbits (female/male, albino; 2-3 kg) 
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were taken from the Centre for Animal Resources, National University of 
Singapore, and housed in the Conventional Rabbit Cage System (Temperature: 
18-22 °C; Humidity: 30-70%). The rabbits were acclimatized for at least 5 
days prior to the test. Fur on both sides of the rabbit’s spine was clipped 
approximately 24 hours before the test. Each of the clipped areas was about 
10cm × 15cm. Hydrogel and 0.9% NaCl saline (the negative control) were 
applied to the four areas on the back of each rabbit: two for the hydrogel and 
two for the negative control. The doses of the hydrogel and the negative 
control for each area were 0.5 g and 0.5 mL respectively. Each application site 
was then covered by a gauze patch secured with occlusive dressing. After 4 
hours of exposure, the gauze patch and dressing were removed. The residual 
hydrogel was removed by washing with water and the skin was dried carefully. 
Observation was made at 1, 24, 48 and 72 hours after the removal of the test 
and control substances. The erythema/eschar and oedema formation were rated 
in all the application sites based on the Draize grading scale. The average 
scores of the erythema and oedema formation were 0 during the 72-hour 





1. I. Wiegand, K. Hilpert and R. E. Hancock, Nat. Protoc., 2008, 3, 
163-175.  
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Appendix C: Synthetic procedures and characterization of polymers 
containing dopamine, cations and PEG 
C1. Methods 
Neutralization of dopamine.HCl 
Neutralization of dopamine.HCl was performed according to a procedure 
reported previously.1 DopamineHCl (1.9 g, 0.01 mol) was dissolved in 10 mL 
of de-ionized (DI) water and cooled down to 4 C, and 10 mL of 1 M cold 
NaOH solution was then added dropwise to the solution under stirring. The 
reaction solution was stirred for 10 min before it was freeze-dried. The 
resulting solid was dissolved in 50 mL of MeOH, and filtered. The filtrate was 
concentrated to dryness and dried in vacuo, giving light brown powder. 1H 
NMR (400 MHz, D2O, 22 °C): δ 6.63 (d, 1H, PhH), 6.56 (d, 1H, PhH), 6.43 (d, 
1H, PhH), 3.02 (t, 3H, -PhCH2-), 2.66 (t, 3H, -CH2NH2).  
Monomer synthesis 
Synthesis of MTC-BnCl (Scheme C1a) 
Into a dry THF solution (100 mL) of MTC-OH (4.8 g, 30 mmol), a 
solution of oxalyl chloride (3.8 mL, 45 mmol) in dry THF (50 mL) was gently 
added over 20 min under N2 atmosphere after a catalytic amount (3 drops) of 
DMF was added. After the solution was stirred for 1 h, it was bubbled with a 
N2 flow to remove volatiles, and then evaporated under vacuum. 
A mixture of 4-(chloromethyl)benzyl alcohol (4.35 g, 28 mmol) and 
pyridine (2.4 mL, 30 mmol) in dry THF (50 mL) was dropped stepwise to a 
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dry THF solution (100 mL) of the intermediate MTC-Cl over 30 min at 0 °C 
with ice bath. After 30 min, the ice bath was removed and the reaction mixture 
was kept with stirring for 3 h at room temperature. More DCM was then added 
and the solution was transferred to a separation funnel, washed 3 times with 
brine and dried over MgSO4 overnight. Finally, the reaction solution was 
concentrated to dryness after filtration, and the obtained crude product was 
purified by a silica gel column using a gradient eluting of a mixture of ethyl 
acetate and hexane (50/50 to 80/20) to provide the product MTC-BnCl as a 
colorless oil that slowly solidified to a white solid (6.7 g, 80%). 1H NMR (400 
MHz, CDCl3, 22 °C): δ 7.36 (dd, 4H, PhH), 5.21 (s, 2H, -OCH2Ph-), 4.69 (d, 
2H, -CH2OCOO-), 4.58 (s, 2H, -PhCH2Cl), 4.20 (d, 2H, -CH2OCOO-), 1.32 (s, 
3H, -CH3). 
Synthesis of MTC-PEG (Scheme C1b) 
Monomethoxy poly (ethylene glycol) (PEG, 4.5 g, 6 mmol) was charged 
into a 250 mL three-neck round bottom flask and heated to 82 C in vacuo 
with stirring overnight to remove moisture. After being cooled down to room 
temperature, a solution of MTC-OH (1.44 g, 9 mmol) in dry THF (50 mL) was 
added to the flask under N2 atmosphere, followed by gently adding a solution 
of N,N'-dicyclohexylcarbodiimide (DCC, 2.48 g, 12 mmol) in dry THF (50 
mL) and stirred for 48 hours. The reaction solution was then filtered and 
concentrated to dryness. The resulting crude product was purified by column 
chromatography on a Sephadex LH-20 column with THF as eluent, giving 
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pure MTC-PEG as a white viscous solid (4.6 g, 83%). 1H NMR (400 MHz, 
CDCl3, 22 °C): δ 4.45 (dd, 4H, -CH2OCOO-), 4.35 (d, 2H, -COOCH2-MPEG), 
3.65 (s, 68H, H of MPEG), 1.34 (s, 3H, -CH3). 
Polymer synthesis 
Synthesis of dopamine-containing cationic 
poly[(MTC-dopamine)x-ran-(MTC-OBnCl)y-ran-(MTC-PEG)z] 
The details of the procedure for preparation of 4b’’ are given below as a 
typical example of brush-like cationic polycarbonates containing dopamine 
and short PEG. Under nitrogen atmosphere, 
4-MBA-poly[(MTC-OBnCl)58-ran-(MTC-PEG)10] (0.6 g, 0.021 mmol) was 
added to dopamine solution (48 mg, 0.27 mmol) in a mixture of DMSO (10 
mL), acetonitrile (10 mL) and isopropanol (10 mL), and reacted for 10 h. After 
that, N,N-dimethyl benzylamine (DMBA, 2.0 mL, 13.6 mmol) was added to 
the reaction solution, and stirred overnight. The reaction solution was then 
concentrated and dialyzed against the mixture of acetonitrile and isopropanol 
(1:1, the molecular weight cut-off (MWCO) of dialysis membrane: 1,000 Da) 
for 2 days. The solution was concentrated to dryness and the resulting product 
was dried in vacuo to give 4b’’ as a brown viscous solid (0.62 g, 80%). 1H 
NMR (400 MHz, DMSO-d6, 22 °C): δ 7.48 (m, 506H, PhH), 6.20-6.70 (m, 
12H, PhH of dopamine), 5.16 (s, 118H, -OCH2Ph- and -OCH2PhCH3), 4.75 (s, 
br, 216H, -PhCH2N(CH3)2(CH2Ph)), 4.26 (s, 292H, -CH2OCOO- and 
-COOCH2-MPEG), 3.50 (s, 688, -PhCH2-dopamine and H of MPEG), 2.89 (s, 
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324H, -PhCH2N(CH3)2(CH2Ph)), 2.32 (s, 3H, -CH3Ph of 4-MBA), 1.18 (s, 
204H, -CH3). The number of MTC-dopamine and MTC-OBn-DMBA in the 
cationic polymer is 4 and 54 respectively. The number of MTC-dopamine was 
estimated by comparing the integral of ethylene proton of PEG at 3.50 ppm 
(The integral intensity of the methylene protones of -PhCH2-dopamine was 
deducted due to overlapping) with that of phenyl proton of dopamine at 
6.20-6.70 ppm. The difference between the numbers of MTC-OBnCl and 
MTC-dopamine is the number of MTC-OBn-DMBA. 
4b, 1H NMR (400 MHz, DMSO-d6, 22 °C): δ 7.52 (d, 260H, PhH), 6.30-6.70 
(m, 12H, PhH of dopamine), 5.17 (s, 130H, -OCH2Ph- and -OCH2- of 
4-MBA), 4.65 (s, br, 120H, -PhCH2N(CH3)3), 4.27 (s, 316H, -CH2OCOO- 
and -COOCH2-MPEG), 3.50 (s, 688H, -PhCH2-dopamine and H of MPEG), 
3.07 (s, 540H, -PhCH2N(CH3)3), 2.32 (s, 3H, -CH3Ph of 4-MBA), 1.16 (s, 
222H, -CH3). 
4b’’, 1H NMR (400 MHz, DMSO-d6, 22 °C): δ 7.58 (d, 224H, PhH), 6.21-6.63 
(m, 12H, PhH of dopamine), 5.16 (s, 112H, -OCH2Ph- and -OCH2- of 
4-MBA), 4.65 (s, br, 102H, -PhCH2N(CH3)2CH2-), 4.27 (s, 268H, 
-CH2OCOO- and -COOCH2-MPEG), 3.50 (s, 552H, -PhCH2-dopamine and H 
of MPEG), 2.87 (d, 408H, -PhCH2N(CH3)2CH2-), 2.33 (s, 3H, -CH3Ph of 
4-MBA), 1.74 (s, 102H, -CH2CH2CH3), 1.10-1.29 (m, 291H, -CH2CH2CH3 
and -CH3 of MTCs), 0.92 (m, 153H, -CH2CH2CH3). 
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Gel permeation chromatograph (GPC) 
GPC analysis for the precursor polymer 
poly[(MTC-OBnCl)58-ran-(MTC-PEG)10] was carried out with a Waters 
HPLC system equipped with a 2690D separation module with two Styragel 
HR1 and HR4E (THF) 5 m columns (size: 300 × 7.8 mm) in series and a 
Waters 410 differential refractometer detector. The mobile phase used was 
THF with a flow rate of 1 mL/min. Weight average molecular weight and 
polydispersity index were calculated from a calibration curve using a series of 
polystyrene standards with molecular weight ranging from 1,350 to 151,700. 
1H NMR spectroscopy 
1H NMR spectra were recorded on a Bruker Advance 400 NMR 
spectrometer at 400 MHz at room temperature. The 1H NMR measurements 
were carried out with an acquisition time of 3.2 s, a pulse repetition time of 2.0 
s, a 30° pulse width, 5208-Hz spectral width, and 32 K data points. Chemical 
shifts were referred to the solvent peaks (δ = 7.26 and 2.50 ppm for CDCl3 and 
DMSO-d6, respectively). 




Scheme C1 Synthesis procedures and structures of MTC-BnCl (a) and 
MTC-PEG (b). 
 
C2 Results and discussion on the synthesis and characterization of 
polymer containing cations, PEG and dopamine 
The brush-like polycarbonates were synthesized by copolymerization of a 
cyclic carbonate monomer containing pendent benzyl chloride group 
(MTC-BnCl) with a cyclic carbonate monomer containing pendent PEG group 
(MTC-PEG) (Scheme C1) using 4-methylbenzyl alcohol (4-MBA) as the 
initiator, and N-(3,5-trifluoromethyl) phenyl-N’-cyclohexylthiourea 
(TU)/1,8-diazabicyclo [5,4,0]undec-7-ene) (DBU) as co-catalysts to facilitate 
polymerization (Scheme 4.1a). The amount of co-catalysts used was crucial to 
this polymerization. When a relatively smaller amount of co-catalysts were 
added, the polymerization was incomplete, leading to a large amount of 
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relatively larger amount of co-catalysts yielded polymers with a bimodal 
distribution of molecular weights in the chromatogram of gel permeation 
chromatography. To circumvent these problems, the co-catalysts were added 
to the reaction mixture in a stepwise fashion: 1) 20% of the total amount of 
TU was first added to initiate the polymerization for 20 min, 2) the remaining 
80% of the TU and DBU were then added to ensure a complete reaction. As 
shown in Figure C1, the resulting polymer has a narrow molecular weight 
distribution with a monomodal peak in the GPC trace (polydispersity index; 
PDI: 1.20). The polymerization degree of the precursor polymer was estimated 
by comparing the integral of methyl proton of 4-MBA at 2.24 ppm to that of 
methylene proton of pendent BnCl at 4.54 ppm and that of ethylene proton of 
PEG at 3.64 ppm in the 1H NMR spectrum (Figure C2a). Using this method, a 
series of polycarbonates containing varying compositions of pendent benzyl 
chloride and PEG units could be synthesized by varying the feed ratio of the 
monomers.  
Free dopamine was incorporated into the polycarbonate via nucleophilic 
substitution of the pendent benzyl chloride (BnCl) groups with the primary 
amine group of dopamine. Free dopamine was prepared by neutralization of 
dopamineHCl with sodium hydroxide at low temperature. To examine if the 
primary amine of dopamine causes degradation of the polycarbonate backbone 
during the substitution reaction, a random copolymer of 65 MTC-BnCl and 10 
MTC-PEG units was conjugated with dopamine. The degree of dopamine 
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functionalization was quantified by 1H NMR spectroscopy, by comparing the 
integration of the methyl protons of 4-MBA at 2.26 ppm against that of the 
phenyl protons of dopamine at 6.20-6.70 ppm (Figure C2b). Interestingly, 
despite an excess amount of dopamine being used relative to the number of 
available BnCl groups in the substitution reaction, only about 4 out of 
available 65 BnCl moieties per polymer chain reacted with the free dopamine. 
The number of the free BnCl moieties after the substitution reaction was 
determined to be 61 by comparison of the intensity of the methylene protons 
of -PhCH2Cl of BnCl at 4.67 ppm to that of the methyl hydrogens of 4-MBA 
at 2.26 ppm (Figure C2b). The total 65 units of MTC-dopamine and 
MTC-BnCl in the dopamine-substituted polymer chain are in good agreement 
with the number of the available MTC-BnCl units before the nucleophilic 
substitution, indicating that the primary amine of free dopamine did not break 
down the polycarbonate backbone. The degree of dopamine funtionalization 
could be tuned by adjusting the feed ratio of free dopamine to BnCl groups in 
the substitution reaction (Table C1).   
The remaining pendent BnCl groups in the polymer were subsequently 
quaternized with a large excess of trimethylamine (TMA), 
N,N-dimethylbutylamine or N,N-dimethylbenzylamine. Successful 
quaternization was confirmed by 1H NMR spectroscopy (see Figure C2c). 
Unfortunately, as a consequence of their intended adhesive properties, neither 
final product nor its dopamine-functionalized precursor were amenable to 
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GPC analysis. However, the polymer did not degrade under the mild 
quaternization condition (room temperature) according to our previous 
studies.2  The compositions of polymers 4b, 4b’ and 4b’’ as typical examples 
were analyzed according to their 1H NMR spectra and listed in Scheme 4.1A.  
 
Figure C1 GPC diagram of polymerization precursor obtained after step 1 
shown in Scheme 4.1A. 
 
 
Figure C2. 1H NMR spectra of precursor polymer obtained after step 1 shown 
in Scheme 4.1A in CDCl3 (a), dopamine-conjugated polymer in DMSO-d6 (b), 
which was synthesized to examine if the primary amine of dopamine causes 
degradation of the polycarbonate backbone during the nucleophilic 
substitution reaction, and polymer 4b’’ in DMSO-d6 (c). 
 
5 10 15 20
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Table C1. Incorporation ability of dopamine into polymerization precursor in 
step 2 (Scheme 4.1A). 
 
Sample name 
Molar ratio of 
dopamine to polymer 
in the feed 
Molar ratio of dopamine to 
polymer in 1H NMR 
spectrum 
4b control polymer 
with 2 moles of 
dopamine 
5:1 2 
4b 12.5:1 4 
4b control polymer 
with 10 moles of 
dopamine 
25:1 10 
4b’ 12.5:1 4 
4b’’ 12.5:1 4 
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